
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer Patients - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="ABCBA84E9264D2633DA84E00093EDE75.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="transoncol">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6931216/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Translational Oncology">
<meta name="citation_title" content="Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer Patients">
<meta name="citation_author" content="Dolores Gallardo-Rincón">
<meta name="citation_author_institution" content="Ovarian Cancer Program, Instituto Nacional de Cancerología, Mexico City, Mexico">
<meta name="citation_author_institution" content="Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico">
<meta name="citation_author" content="Rosa María Álvarez-Gómez">
<meta name="citation_author_institution" content="Hereditary Cancer Clinic, Instituto Nacional de Cancerología, Mexico City, Mexico">
<meta name="citation_author" content="Edgar Montes-Servín">
<meta name="citation_author_institution" content="Ovarian Cancer Program, Instituto Nacional de Cancerología, Mexico City, Mexico">
<meta name="citation_author" content="Alfredo Toledo-Leyva">
<meta name="citation_author_institution" content="Ovarian Cancer Program, Instituto Nacional de Cancerología, Mexico City, Mexico">
<meta name="citation_author" content="Elizabeth Montes-Servín">
<meta name="citation_author_institution" content="Ovarian Cancer Program, Instituto Nacional de Cancerología, Mexico City, Mexico">
<meta name="citation_author" content="David Michel-Tello">
<meta name="citation_author_institution" content="Ovarian Cancer Program, Instituto Nacional de Cancerología, Mexico City, Mexico">
<meta name="citation_author" content="Gabriela Alamilla-García">
<meta name="citation_author_institution" content="Ovarian Cancer Program, Instituto Nacional de Cancerología, Mexico City, Mexico">
<meta name="citation_author" content="Antonio Bahena-González">
<meta name="citation_author_institution" content="Ovarian Cancer Program, Instituto Nacional de Cancerología, Mexico City, Mexico">
<meta name="citation_author" content="Elizabeth Hernández-Nava">
<meta name="citation_author_institution" content="Ovarian Cancer Program, Instituto Nacional de Cancerología, Mexico City, Mexico">
<meta name="citation_author" content="Veronica Fragoso-Ontiveros">
<meta name="citation_author_institution" content="Hereditary Cancer Clinic, Instituto Nacional de Cancerología, Mexico City, Mexico">
<meta name="citation_author" content="Raquel Espinosa-Romero">
<meta name="citation_author_institution" content="Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico">
<meta name="citation_author" content="Lucely Cetina-Pérez">
<meta name="citation_author_institution" content="Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico">
<meta name="citation_publication_date" content="2019 Dec 20">
<meta name="citation_volume" content="13">
<meta name="citation_issue" content="2">
<meta name="citation_firstpage" content="212">
<meta name="citation_doi" content="10.1016/j.tranon.2019.11.003">
<meta name="citation_pmid" content="31869745">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC6931216/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC6931216/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC6931216/pdf/main.pdf">
<meta name="description" content="Ovarian cancer (OC) is an important cause of gynecologic cancer-related deaths. In Mexico, around 4700 new cases of OC are diagnosed per year and it represents the second cause of gynecological cancer mortality with more than 2700 deaths. Germline ...">
<meta name="og:title" content="Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer Patients">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Ovarian cancer (OC) is an important cause of gynecologic cancer-related deaths. In Mexico, around 4700 new cases of OC are diagnosed per year and it represents the second cause of gynecological cancer mortality with more than 2700 deaths. Germline ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC6931216/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="6931216">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1016/j.tranon.2019.11.003"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/main.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC6931216%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/6931216/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/6931216/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC6931216/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-transoncol.gif" alt="Translational Oncology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Translational Oncology" title="Link to Translational Oncology" shape="default" href="http://www.transonc.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Transl Oncol</button></div>. 2019 Dec 20;13(2):212–220. doi: <a href="https://doi.org/10.1016/j.tranon.2019.11.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1016/j.tranon.2019.11.003</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Transl%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Transl%20Oncol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Transl%20Oncol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Transl%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Clinical Evaluation of <em>BRCA1/2</em> Mutation in Mexican Ovarian Cancer Patients</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gallardo-Rinc%C3%B3n%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Dolores Gallardo-Rincón</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Dolores Gallardo-Rincón</span></h3>
<div class="p">
<sup>∗</sup>Ovarian Cancer Program, Instituto Nacional de Cancerología, Mexico City, Mexico</div>
<div class="p">
<sup>‡</sup>Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gallardo-Rinc%C3%B3n%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Dolores Gallardo-Rincón</span></a>
</div>
</div>
<sup>∗,</sup><sup>‡,</sup><sup>∗,</sup><sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22%C3%81lvarez-G%C3%B3mez%20RM%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Rosa María Álvarez-Gómez</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Rosa María Álvarez-Gómez</span></h3>
<div class="p">
<sup>†</sup>Hereditary Cancer Clinic, Instituto Nacional de Cancerología, Mexico City, Mexico</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22%C3%81lvarez-G%C3%B3mez%20RM%22%5BAuthor%5D" class="usa-link"><span class="name western">Rosa María Álvarez-Gómez</span></a>
</div>
</div>
<sup>†,</sup><sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Montes-Serv%C3%ADn%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Edgar Montes-Servín</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Edgar Montes-Servín</span></h3>
<div class="p">
<sup>∗</sup>Ovarian Cancer Program, Instituto Nacional de Cancerología, Mexico City, Mexico</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Montes-Serv%C3%ADn%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Edgar Montes-Servín</span></a>
</div>
</div>
<sup>∗</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Toledo-Leyva%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Alfredo Toledo-Leyva</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Alfredo Toledo-Leyva</span></h3>
<div class="p">
<sup>∗</sup>Ovarian Cancer Program, Instituto Nacional de Cancerología, Mexico City, Mexico</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Toledo-Leyva%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alfredo Toledo-Leyva</span></a>
</div>
</div>
<sup>∗</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Montes-Serv%C3%ADn%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Elizabeth Montes-Servín</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Elizabeth Montes-Servín</span></h3>
<div class="p">
<sup>∗</sup>Ovarian Cancer Program, Instituto Nacional de Cancerología, Mexico City, Mexico</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Montes-Serv%C3%ADn%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Elizabeth Montes-Servín</span></a>
</div>
</div>
<sup>∗</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Michel-Tello%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">David Michel-Tello</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">David Michel-Tello</span></h3>
<div class="p">
<sup>∗</sup>Ovarian Cancer Program, Instituto Nacional de Cancerología, Mexico City, Mexico</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Michel-Tello%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">David Michel-Tello</span></a>
</div>
</div>
<sup>∗</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alamilla-Garc%C3%ADa%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Gabriela Alamilla-García</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Gabriela Alamilla-García</span></h3>
<div class="p">
<sup>∗</sup>Ovarian Cancer Program, Instituto Nacional de Cancerología, Mexico City, Mexico</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alamilla-Garc%C3%ADa%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Gabriela Alamilla-García</span></a>
</div>
</div>
<sup>∗</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bahena-Gonz%C3%A1lez%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Antonio Bahena-González</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Antonio Bahena-González</span></h3>
<div class="p">
<sup>∗</sup>Ovarian Cancer Program, Instituto Nacional de Cancerología, Mexico City, Mexico</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bahena-Gonz%C3%A1lez%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Antonio Bahena-González</span></a>
</div>
</div>
<sup>∗</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hern%C3%A1ndez-Nava%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Elizabeth Hernández-Nava</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Elizabeth Hernández-Nava</span></h3>
<div class="p">
<sup>∗</sup>Ovarian Cancer Program, Instituto Nacional de Cancerología, Mexico City, Mexico</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hern%C3%A1ndez-Nava%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Elizabeth Hernández-Nava</span></a>
</div>
</div>
<sup>∗</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fragoso-Ontiveros%20V%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Veronica Fragoso-Ontiveros</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Veronica Fragoso-Ontiveros</span></h3>
<div class="p">
<sup>†</sup>Hereditary Cancer Clinic, Instituto Nacional de Cancerología, Mexico City, Mexico</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fragoso-Ontiveros%20V%22%5BAuthor%5D" class="usa-link"><span class="name western">Veronica Fragoso-Ontiveros</span></a>
</div>
</div>
<sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Espinosa-Romero%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Raquel Espinosa-Romero</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Raquel Espinosa-Romero</span></h3>
<div class="p">
<sup>‡</sup>Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Espinosa-Romero%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Raquel Espinosa-Romero</span></a>
</div>
</div>
<sup>‡</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cetina-P%C3%A9rez%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Lucely Cetina-Pérez</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Lucely Cetina-Pérez</span></h3>
<div class="p">
<sup>‡</sup>Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cetina-P%C3%A9rez%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lucely Cetina-Pérez</span></a>
</div>
</div>
<sup>‡</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>∗</sup>Ovarian Cancer Program, Instituto Nacional de Cancerología, Mexico City, Mexico</div>
<div id="aff2">
<sup>†</sup>Hereditary Cancer Clinic, Instituto Nacional de Cancerología, Mexico City, Mexico</div>
<div id="aff3">
<sup>‡</sup>Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico</div>
<div class="author-notes p">
<div class="fn" id="cor1">
<sup>∗</sup><p class="display-inline">Address all correspondence to: Dolores Gallardo-Rincón, Head of Ovarian Cancer Program, Instituto Nacional de Cancerología (INCan), San Fernando 22, Sección XVI, Tlalpan, Mexico City 14080, Mexico. <span>dgallardorincon@gmail.com</span></p>
</div>
<div class="fn" id="fn1">
<sup>1</sup><p class="display-inline" id="ntpara0010">Both authors contributed equally to this work.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2019 Sep 12; Revised 2019 Oct 30; Accepted 2019 Nov 6; Collection date 2020 Feb.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2019 The Authors</div>
<p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC6931216  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31869745/" class="usa-link">31869745</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abs0010"><h2>Abstract</h2>
<p>Ovarian cancer (OC) is an important cause of gynecologic cancer-related deaths. In Mexico, around 4700 new cases of OC are diagnosed per year and it represents the second cause of gynecological cancer mortality with more than 2700 deaths. Germline mutations in <em>BRCA1/2</em> genes are present in 13–18% of OC cases. Few studies have evaluated the presence of mutations in BRCA genes in a population of OC Mexican patients and their relationship with clinical response and survival rates.</p>
<p>A total of 179 OC patients were studied by molecular testing for <em>BRCA1/2</em> through next-generation sequencing and multiplex ligation-dependent probe amplification. Recurrence-free survival (RFS) was estimated by the Kaplan–Meier method. <em>BRCA</em> mutation was detected in 33% of patients. A percentage of 66.1% were <em>BRCA1</em> mutated and 33.9% were <em>BRCA2</em> mutated. <em>BRCA1</em> mutation carriers had a worst RFS compared with <em>BRCA2</em> mutation carriers (37.6 [29–46.2] vs 72.7 [38.4–107.2]; <em>P</em> = 0.030). The most common mutation for <em>BRCA1</em> was ex9-12del (28.2%) (Mexican founder mutation). The Mexican founder mutation had a better RFS than other <em>BRCA1</em> mutations (86.1 [37.2–135.1] vs 34.5 [20.7–48.2]; <em>P</em> = 0.033). The presence of <em>BRCA2</em> mutations in the ovarian cancer cluster region (OCCR) had a significantly better RFS than mutations in breast cancer cluster regions (BCCR) and not-related risk region (NRR) (NR vs 72.8 [39–106.6] vs 25.8 [8.3–43.2]; <em>P</em> = 0.013). These results demonstrate that the prevalence of <em>BRCA1/2</em> positive patients in OC Mexican patients are the highest reported. Patients with mutations in <em>BRCA2</em> have a better prognosis than those mutated in <em>BRCA1</em>. The Mexican founder mutation has an important role in clinical outcomes. These results highlight the importance to test all the HGSP (high-grade serous papillary) OC patients with or without cancer family history (CFH) in Mexican population.</p>
<section id="kwrds0010" class="kwd-group"><p><strong>Abbreviations:</strong> OC, ovarian cancer; CFH, cancer family history; CS, clinical stage; HGSP, high-grade serous papillary; CBP/TXL, carboplatin/paclitaxel; NGS, next-generation sequencing; OCCR, ovarian cancer cluster region; BCCR, breast cancer cluster region; NRR, not-related risk region; RFS, recurrence-free survival; OS, overall survival; NR, non reached</p></section></section><section id="sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="p0010">In the world, there are 295,414 new cases and 184,799 ovarian cancer (OC) deaths per year. In Mexico, around 4759 OC new cases are diagnosed and it represents the second cause of gynecological cancer mortality with 2765 deaths (GLOBOCAN 2018).</p>
<p id="p0015">A family history of breast and ovarian cancer has been associated with an increased probability of a genetic predisposition to these cancers <a href="#bib1" class="usa-link" aria-describedby="bib1">[1]</a>. This risk is increased twice when the history of an affected second-degree relative is present and increased up to four times greater when dealing with a relative in the first degree <a href="#bib2" class="usa-link" aria-describedby="bib2">[2]</a>. A Mexican population study found that less than 10% of OC patients had cancer family history (CFH) <a href="#bib3" class="usa-link" aria-describedby="bib3">[3]</a>. The exploration of familial associations of OC with other cancers suggests that OC shares susceptibility with colorectal, breast, endometrium, liver cancer, and cancer of unknown primary <a href="#bib4" class="usa-link" aria-describedby="bib4">[4]</a>. This evidence suggests that these associations should have implications in genetic counseling. According to previous studies, 13–18% of OC is associated with germline mutations in <em>BRCA1/2</em> genes <a href="#bib5" class="usa-link" aria-describedby="bib5">[5]</a>, <a href="#bib6" class="usa-link" aria-describedby="bib6">[6]</a>, <a href="#bib7" class="usa-link" aria-describedby="bib7">[7]</a>.</p>
<p id="p0020"><em>BRCA1/2</em>, also known as breast cancer susceptibility genes 1 and 2, are tumor suppressor genes. More than one thousand mutations have been described and may be inherited in an autosomal dominant manner <a href="#bib8" class="usa-link" aria-describedby="bib8">[8]</a>. BRCA1 is a DNA damage response protein and works in both checkpoint activation and DNA repair. BRCA2 is a mediator of homologous recombination <a href="#bib9" class="usa-link" aria-describedby="bib9">[9]</a>, <a href="#bib10" class="usa-link" aria-describedby="bib10">[10]</a>. These are essential activities to prevent tumor development.</p>
<p id="p0025">A study in Mexican OC patients found a prevalence of 28% of mutations in <em>BRCA1/2</em> genes <a href="#bib3" class="usa-link" aria-describedby="bib3">[3]</a>.</p>
<p id="p0030">In some specific populations such as Ashkenazi Jews, there is a higher prevalence of mutations in the BRCA1/2 genes, which in turn increases the risk by 65% for breast cancer and 40% for ovarian cancer. This risk is because of the presence of three founder mutations (<em>BRCA1 185delAG</em>, <em>BRCA1 538insC</em>, and <em>BRCA2 6174delT</em>). Around 2.5% of that population carries at least one of those mutations <a href="#bib11" class="usa-link" aria-describedby="bib11">[11]</a>, <a href="#bib12" class="usa-link" aria-describedby="bib12">[12]</a>.</p>
<p id="p0035">There are five OC histological subtypes: high-grade serous papillary (HGSP), endometrioid, mucinous, clear cells, and low-grade serous papillary (LGSP); <em>BRCA1/2</em> mutation is more commonly associated with the HGSP subtype. Patients carrying mutations in <em>BRCA</em> have a better response to treatment and are less likely to have a progression of the disease within six months after the end of primary therapy compared with those who do not have the mutation (14.9% vs 31.7%; <em>P</em> &lt; 0.0001) <a href="#bib5" class="usa-link" aria-describedby="bib5">[5]</a>.</p>
<p id="p0040">There are currently few studies that assessed the presence of <em>BRCA</em> mutations in the Mexican population. The purpose of this study was to corroborate, in a population of Mexican OC patients, the presence of germline mutations in the <em>BRCA1/2</em> genes and their correlation with clinicopathological characteristics, clinical response, and survival rates.</p></section><section id="sec2"><h2 class="pmc_sec_title">Material and Methods</h2>
<section id="sec2.1"><h3 class="pmc_sec_title">Study Design</h3>
<p id="p0045">A total of 179 patients with OC in clinical stages (CS) IA to IVB were enrolled from October 2015 to August 2017 at the National Institute of Cancer in Mexico. All patients provided written informed consent before entering the study. Inclusion criteria were adult patients (&gt;18 years), diagnosed with OC with a histopathological confirmation. Clinicopathological characteristics (age, sex, born city, CFH), medical treatment, and clinical outcomes of patients were recorded. Patients received pre- and posttest genetic counseling, according to international recommendations, as well as follow-up by geneticists. Cascade screening for relatives was also provided.</p></section><section id="sec2.2"><h3 class="pmc_sec_title">Genetic Testing for BRCA Mutations</h3>
<p id="p0050">Samples of 16 mL of blood from each patient were obtained and drawn into two 8 mL EDTA tubes (BD Biosciences). The next-generation sequencing (NGS) that interrogates all coding regions and up to 50 bases in each intronic region to detect small mutations in the <em>BRCA1/2</em> genes was carried out at the clinical laboratory (Quest Diagnostics, US). To identify exon deletions and duplications, named large rearrangements of <em>BRCA1</em>/<em>2,</em> a multiplex ligation-dependent probe amplification (MLPA) was used. The mutation status was correlated with the standard clinicopathological characteristics of the patients. The analytical sensitivity was &gt;99% of relevant mutations occurring in the described regions.</p>
<p id="p0055">The clinical significance of the variants was determined according to the guidelines established by the international consortium ENIGMA (evidence-based network for the interpretation of germline mutant alleles) and ClinVar database which was provided by the Quest Diagnostics laboratory.</p></section><section id="sec2.3"><h3 class="pmc_sec_title">Statistical Analyses</h3>
<p id="p0060">Continuous variables were tabulated as medians with ranges, or as means with standard deviations, depending on data's distribution. The distribution was assessed using the Shapiro–Wilk test with a <em>P</em>-value higher than 0.05 considered as normally distributed. Two groups' comparisons were tested using Student's <em>T</em>-test or Mann–Whitney <em>U</em>. Nominal data were analyzed using the chi-square (<em>χ</em><sup>2</sup>) test. RFS was calculated as the difference between the date of recurrence or the last follow-up and the beginning of surveillance of first-line treatment. RFS curves were estimated by the Kaplan–Meier method, whereas comparisons among groups were analyzed with log-rank or Breslow tests. Statistically significant and borderline variables (<em>P</em> ≤ 0.05) were included in the multivariate analyses. All data were analyzed using the SPSS software package version 23 (SPSS, Inc., Chicago, IL, US).</p></section></section><section id="sec3"><h2 class="pmc_sec_title">Results</h2>
<section id="sec3.1"><h3 class="pmc_sec_title">Total Population Characteristics</h3>
<p id="p0065">A total of 179 OC patients were studied. Median patients' age was 48 years, with the majority between 35 and 54 years old. We tested patients from 19 out of 32 states in our country. Positive CFH was reported in 63.7% of patients, and the most common familial cancer type reported was breast cancer (51.8%). The most common histological subtype and CS were HGSP and IIIC, respectively (69.3% and 45.8%). Twenty-four patients (13.4%) had a double primary malignancy, the most frequent being breast/ovarian (79.2%). The most common chemotherapy schedule administrated as a primary treatment was carboplatin and paclitaxel every three weeks (87.7%). Rates of complete response, partial response, stable disease, and progression of the disease with primary treatment were 57%, 27.4%; 5.6%, and 10.1%, respectively (<a href="#tbl1" class="usa-link">Table 1</a>).</p>
<section class="tw xbox font-sm" id="tbl1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Baseline and Clinical Characteristics of Ovarian Cancer Patients</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th colspan="1" rowspan="1">Characteristics</th>
<th colspan="1" rowspan="1">Total</th>
</tr></thead>
<tbody>
<tr><td colspan="2" rowspan="1">Age (years) at diagnosis</td></tr>
<tr>
<td colspan="1" rowspan="1"> Median (range)</td>
<td colspan="1" rowspan="1">48 (18–76)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Mean ± SD</td>
<td colspan="1" rowspan="1">49.4 ± 10.6</td>
</tr>
<tr><td colspan="2" rowspan="1">Group of age at diagnosis</td></tr>
<tr>
<td colspan="1" rowspan="1"> ≤34</td>
<td colspan="1" rowspan="1">4.5 (8/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 35–44</td>
<td colspan="1" rowspan="1">32.4 (58/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 45–54</td>
<td colspan="1" rowspan="1">32.4 (58/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 55–64</td>
<td colspan="1" rowspan="1">21.2 (38/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> ≥65</td>
<td colspan="1" rowspan="1">9.5 (17/179)</td>
</tr>
<tr><td colspan="2" rowspan="1">Born city</td></tr>
<tr>
<td colspan="1" rowspan="1"> Aguascalientes</td>
<td colspan="1" rowspan="1">0.6 (1/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> CDMX</td>
<td colspan="1" rowspan="1">38 (68/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Chihuahua</td>
<td colspan="1" rowspan="1">0.6 (1/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Coahuila</td>
<td colspan="1" rowspan="1">0.6 (1/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Guanajuato</td>
<td colspan="1" rowspan="1">1.1 (2/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Guerrero</td>
<td colspan="1" rowspan="1">1.7 (3/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Hidalgo</td>
<td colspan="1" rowspan="1">8.9 (16/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Jalisco</td>
<td colspan="1" rowspan="1">1.1 (2/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> México</td>
<td colspan="1" rowspan="1">24.6 (44/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Michoacán</td>
<td colspan="1" rowspan="1">4 (7/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Morelos</td>
<td colspan="1" rowspan="1">2.8 (5/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Oaxaca</td>
<td colspan="1" rowspan="1">1.7 (3/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Puebla</td>
<td colspan="1" rowspan="1">4.5 (8/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Querétaro</td>
<td colspan="1" rowspan="1">2.2 (4/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> San Luis Potosí</td>
<td colspan="1" rowspan="1">1.1 (2/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Tabasco</td>
<td colspan="1" rowspan="1">0.6 (1/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Tlaxcala</td>
<td colspan="1" rowspan="1">3.4 (6/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Veracruz</td>
<td colspan="1" rowspan="1">2.2 (4/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Zacatecas</td>
<td colspan="1" rowspan="1">0.6 (1/179)</td>
</tr>
<tr><td colspan="2" rowspan="1">CFH</td></tr>
<tr>
<td colspan="1" rowspan="1"> Negative</td>
<td colspan="1" rowspan="1">36.3 (65/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Positive</td>
<td colspan="1" rowspan="1">63.7 (114/179)</td>
</tr>
<tr><td colspan="2" rowspan="1">Type of CFH</td></tr>
<tr>
<td colspan="1" rowspan="1"> Breast</td>
<td colspan="1" rowspan="1">51.8 (59/114)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Prostate</td>
<td colspan="1" rowspan="1">19.3 (22/114)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Ovarian</td>
<td colspan="1" rowspan="1">13.2 (15/114)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Melanoma</td>
<td colspan="1" rowspan="1">9.6 (11/114)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Pancreas</td>
<td colspan="1" rowspan="1">6.1 (7/114)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Endometrium</td>
<td colspan="1" rowspan="1">3.5 (4/114)</td>
</tr>
<tr><td colspan="2" rowspan="1">Number of related cancer associated to BRCA</td></tr>
<tr>
<td colspan="1" rowspan="1"> Not associated</td>
<td colspan="1" rowspan="1">26.3 (30/114)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Associated</td>
<td colspan="1" rowspan="1">73.7 (84/114)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 1</td>
<td colspan="1" rowspan="1">64.3 (54/84)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 2</td>
<td colspan="1" rowspan="1">29.8 (25/84)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 3</td>
<td colspan="1" rowspan="1">6 (5/84)</td>
</tr>
<tr><td colspan="2" rowspan="1">Clinical stage at diagnosis</td></tr>
<tr>
<td colspan="1" rowspan="1"> IA</td>
<td colspan="1" rowspan="1">3.9 (7/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IC</td>
<td colspan="1" rowspan="1">7.8 (14/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IIA/B</td>
<td colspan="1" rowspan="1">7.7 (3/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IIIA</td>
<td colspan="1" rowspan="1">3.4 (6/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IIIB</td>
<td colspan="1" rowspan="1">8.4 (15/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IIIC</td>
<td colspan="1" rowspan="1">45.8 (82/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IVA</td>
<td colspan="1" rowspan="1">11.7 (21/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IVB</td>
<td colspan="1" rowspan="1">17.3 (31/179)</td>
</tr>
<tr><td colspan="2" rowspan="1">Histological subtypes</td></tr>
<tr>
<td colspan="1" rowspan="1"> Clear cells</td>
<td colspan="1" rowspan="1">4.5 (8/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> HGSP</td>
<td colspan="1" rowspan="1">69.3 (124/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> LGSP</td>
<td colspan="1" rowspan="1">5.6 (10/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Mucinous</td>
<td colspan="1" rowspan="1">0.6 (1/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Endometroid</td>
<td colspan="1" rowspan="1">12.8 (23/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> G1</td>
<td colspan="1" rowspan="1">17.4 (4/23)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> G2</td>
<td colspan="1" rowspan="1">69.6 (16/23)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> G3</td>
<td colspan="1" rowspan="1">13 (3/23)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Adenocarcinoma</td>
<td colspan="1" rowspan="1">2.8 (5/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Mixed</td>
<td colspan="1" rowspan="1">4.5 (8/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> HGSP/endometroid</td>
<td colspan="1" rowspan="1">62.5 (5/8)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> HGSP/clear cells</td>
<td colspan="1" rowspan="1">12.5 (1/8)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Endometroid/clear cells</td>
<td colspan="1" rowspan="1">12.5 (1/8)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Endometroid/HGSP</td>
<td colspan="1" rowspan="1">12.5 (1/8)</td>
</tr>
<tr><td colspan="2" rowspan="1">Double primary malignancy</td></tr>
<tr>
<td colspan="1" rowspan="1"> Negative</td>
<td colspan="1" rowspan="1">86.6 (155/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Positive</td>
<td colspan="1" rowspan="1">13.4 (24/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Breast/ovarian</td>
<td colspan="1" rowspan="1">79.2 (19/24)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Endometrium/ovarian</td>
<td colspan="1" rowspan="1">20.8 (5/24)</td>
</tr>
<tr><td colspan="2" rowspan="1">1° Line treatment</td></tr>
<tr>
<td colspan="1" rowspan="1"> CBP/TXL per week</td>
<td colspan="1" rowspan="1">7.8 (14/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> CBP/TXL 3 weeks</td>
<td colspan="1" rowspan="1">87.7 (157/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Other</td>
<td colspan="1" rowspan="1">7.8 (14/179)</td>
</tr>
<tr><td colspan="2" rowspan="1">Line of treatment</td></tr>
<tr>
<td colspan="1" rowspan="1"> 1° Line</td>
<td colspan="1" rowspan="1">38 (68/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 2° Line</td>
<td colspan="1" rowspan="1">27.9 (50/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> ≥3</td>
<td colspan="1" rowspan="1">34.1 (61/179)</td>
</tr>
<tr><td colspan="2" rowspan="1">Treatment response at 1° line of treatment</td></tr>
<tr>
<td colspan="1" rowspan="1"> CR</td>
<td colspan="1" rowspan="1">57 (102/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> PR</td>
<td colspan="1" rowspan="1">27.4 (49/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> SD</td>
<td colspan="1" rowspan="1">5.6 (10/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> PD</td>
<td colspan="1" rowspan="1">10.1 (18/179)</td>
</tr>
<tr><td colspan="2" rowspan="1">Platinum-based therapy</td></tr>
<tr>
<td colspan="1" rowspan="1"> Platinum sensitive</td>
<td colspan="1" rowspan="1">91.6 (164/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Platinum resistant</td>
<td colspan="1" rowspan="1">8.4 (15/179)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn2"><p>CFH = cancer family history.</p></div></div></section></section><section id="sec3.2"><h3 class="pmc_sec_title">Presence of Germinal BRCA Mutations</h3>
<p id="p0070"><em>BRCA</em> mutations were detected in 33% of the patients (59/179); 66.1% (39/59) were <em>BRCA1</em>, and 33.9% (20/59) were <em>BRCA2</em> mutations. The most common mutation for <em>BRCA1</em> carrier patients was <em>BRCA1 ex9-12del</em> (Mexican founder mutation), which was found in 28% (11/39) of cases. Among <em>BRCA2</em> mutations, <em>c.8168 A &gt; G</em> was the most prevalent in 25% (5/20) of cases (<a href="#tbl2" class="usa-link">Table 2</a>).</p>
<section class="tw xbox font-sm" id="tbl2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>BRCA Status of Ovarian Cancer Patients</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th colspan="1" rowspan="1">BRCA status</th>
<th colspan="2" rowspan="1">% (<em>N</em>)</th>
</tr></thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">Wild-type</td>
<td colspan="2" rowspan="1">67 (120/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Mutated</td>
<td colspan="2" rowspan="1">33 (59/179)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> <strong><em>BRCA1</em></strong>
</td>
<td colspan="2" rowspan="1">66.1 (39/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> <strong><em>BRCA2</em></strong><hr>
</td>
<td colspan="2" rowspan="1">33.9 (20/59)<hr>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Mutation<hr>
</td>
<td colspan="1" rowspan="1">% (<em>N</em>)<hr>
</td>
<td colspan="1" rowspan="1">Location<hr>
</td>
</tr>
<tr><td colspan="3" rowspan="1"><em>BRCA1</em></td></tr>
<tr>
<td colspan="1" rowspan="1">1) ex9-12del (Mexican Founder Mutation)</td>
<td colspan="1" rowspan="1">28.2 (11/39)</td>
<td rowspan="10" colspan="1">OCCR</td>
</tr>
<tr>
<td colspan="1" rowspan="1">2) c.2806–2809 del GATA</td>
<td colspan="1" rowspan="1">5.1 (2/39)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">3) c.1860 del T</td>
<td colspan="1" rowspan="1">5.1 (2/39)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">4) c.1723 dup G</td>
<td colspan="1" rowspan="1">2.6 (1/39)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">5) c.1961 del A</td>
<td colspan="1" rowspan="1">2.6 (1/39)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">6) c.2101 A &gt; T</td>
<td colspan="1" rowspan="1">2.6 (1/39)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">7) c.2551 G &gt; T</td>
<td colspan="1" rowspan="1">2.6 (1/39)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">8) c.3598 C &gt; T</td>
<td colspan="1" rowspan="1">2.6 (1/39)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">9) c.3648 dup A</td>
<td colspan="1" rowspan="1">2.6 (1/39)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">10) c.3858–3861 del TGAG</td>
<td colspan="1" rowspan="1">2.6 (1/39)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">11) c.4868 C &gt; G</td>
<td colspan="1" rowspan="1">5.1 (2/39)</td>
<td rowspan="4" colspan="1">BCCR</td>
</tr>
<tr>
<td colspan="1" rowspan="1">12) c.211 A &gt; G</td>
<td colspan="1" rowspan="1">2.6 (1/39)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">13) c.5353 C &gt; T</td>
<td colspan="1" rowspan="1">2.6 (1/39)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">14) exon 18–19 del</td>
<td colspan="1" rowspan="1">5.1 (2/39)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">15) c.4327 C &gt; T</td>
<td colspan="1" rowspan="1">7.7 (3/39)</td>
<td rowspan="4" colspan="1">NRR</td>
</tr>
<tr>
<td colspan="1" rowspan="1">16) c.798–799 del TT</td>
<td colspan="1" rowspan="1">5.1 (2/39)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">17) c.4976 del C</td>
<td colspan="1" rowspan="1">2.6 (1/39)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">18) c.68–69 del AG</td>
<td colspan="1" rowspan="1">2.6 (1/39)</td>
</tr>
<tr><td colspan="3" rowspan="1"><em>BRCA2</em></td></tr>
<tr>
<td colspan="1" rowspan="1">19) c.4325 C &gt; A</td>
<td colspan="1" rowspan="1">10 (2/20)</td>
<td rowspan="6" colspan="1">OCCR</td>
</tr>
<tr>
<td colspan="1" rowspan="1">20) c.5116–5119 del AATA</td>
<td colspan="1" rowspan="1">10 (2/20)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">21) c.4749–4750 del AG</td>
<td colspan="1" rowspan="1">5 (1/20)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">22) c.5542 del A</td>
<td colspan="1" rowspan="1">5 (1/20)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">23) c.5616–5620 del AGTAA</td>
<td colspan="1" rowspan="1">5 (1/20)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">24) c.5631 del C</td>
<td colspan="1" rowspan="1">5 (1/20)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"><strong>25) c.8168 A &gt; G</strong></td>
<td colspan="1" rowspan="1"><strong>25 (5/20)</strong></td>
<td rowspan="2" colspan="1">BCCR</td>
</tr>
<tr>
<td colspan="1" rowspan="1">26) c.1796–1800 del CTTAT</td>
<td colspan="1" rowspan="1">10 (2/20)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn3"><p>OCCR = ovarian cancer cluster region; BCCR = breast cancer cluster region; NRR = not-related risk region.</p></div></div></section></section><section id="sec3.3"><h3 class="pmc_sec_title">Location of BRCA1 and BRCA2 Mutations</h3>
<p id="p0075">A total of 34 variants or mutations were detected in the <em>BRCA</em> genes, 22 mutations in <em>BRCA1</em>, and 12 in <em>BRCA2</em>. The majority of the mutations (74%) were located in the areas known as the ovarian cancer cluster regions (OCCR) and breast cancer cluster regions (BCCR) in both genes (<em>BRCA1/2</em>). Among <em>BRCA1</em> gene mutations, 22 (56.5%) were in the OCCR region, 9 (23%) in the BCCR region, and 8 (20.5%) in the not-related risk region (NRR) (<a href="#tbl2" class="usa-link">Table 2</a>, <a href="#fig1" class="usa-link">Figure 1</a>A). For <em>BRCA2</em> gene mutations, locations in the OCCR, BCCR, and NRR regions were 8 (40%), 7 (35%), and 5 (25%) (<a href="#tbl2" class="usa-link">Table 2</a>, <a href="#fig1" class="usa-link">Figure 1</a>B).</p>
<figure class="fig xbox font-sm" id="fig1" title="Figure 1"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6931216_gr1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8177/6931216/b3a17bfb41f7/gr1.jpg" loading="lazy" height="501" width="740" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>Location of 34 mutations detected in</strong><strong><em>BRCA1/2</em></strong><strong>genes (BRCA exchange database and verified in the ClinVar database).</strong> (A) Location of 22 reported mutations in <em>BRCA1</em> gene. (B) Location of the 12 mutations in <em>BRCA2</em> gene. OCCR, ovarian cancer cluster region; BCCR, breast cancer cluster region; NRR, not-related risk region.</p></figcaption></figure></section><section id="sec3.4"><h3 class="pmc_sec_title">Clinical Significance of Mutations</h3>
<p id="p0080">Genetic variants of <em>BRCA1/2</em> are classified according to the possibility of increasing the risk of developing cancer. Among 22 <em>BRCA1</em> mutation types detected, 81.8% (18/22) were pathogenic and affected 32 of 39 patients (<a href="#tbl2" class="usa-link">Table 2</a>), and 18.1% (4/22) were not yet reviewed variants and affected 7 out of 39 patients (<a href="#appsec1" class="usa-link">Supplementary Table 1</a>).</p>
<p id="p0085">With respect to <em>BRCA2</em>, 12 different mutations types were detected, 66.7% (8/12) were pathogenic mutations and affected 15 of 20 patients (<a href="#tbl2" class="usa-link">Table 2</a>), and 33.3% (4/12) were not yet reviewed variants and affected 5 of 20 patients (<a href="#appsec1" class="usa-link">Supplementary Table 1</a>).</p></section><section id="sec3.5"><h3 class="pmc_sec_title">Correlation Analysis Between Clinicopathological Characteristics and BRCA Mutations</h3>
<p id="p0090">For BRCA mutations carriers, median age was 50 years (range = 27–73). The most common state of birth of BRCA mutations carriers detected was Mexico City (30.5%), followed by the Estado de Mexico (27.1%), Oaxaca and Puebla (5.1%); <em>P</em> = 0.034) (<a href="#tbl3" class="usa-link">Table 3</a>).</p>
<section class="tw xbox font-sm" id="tbl3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Bivariate Analysis of Clinical Characteristics of Ovarian Cancer Patients with BRCA Status</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th rowspan="2" colspan="1">Characteristics</th>
<th colspan="1" rowspan="1">BRCA −<hr>
</th>
<th colspan="1" rowspan="1">BRCA +<hr>
</th>
<th rowspan="2" colspan="1"><em>P</em></th>
</tr>
<tr>
<th colspan="1" rowspan="1">% (<em>N</em>)</th>
<th colspan="1" rowspan="1">% (<em>N</em>)</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="3" rowspan="1">Age (years) at DX</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Median (range)</td>
<td colspan="1" rowspan="1">47 (18–76)</td>
<td colspan="1" rowspan="1">50 (27–73)</td>
<td colspan="1" rowspan="1">0.467</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Mean ± SD</td>
<td colspan="1" rowspan="1">49.1 ± 11.3</td>
<td colspan="1" rowspan="1">49.9 ± 9.1</td>
<td colspan="1" rowspan="1">0.583</td>
</tr>
<tr>
<td colspan="3" rowspan="1">Group of age at DX</td>
<td rowspan="6" colspan="1"><strong>0.041</strong></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> ≤34</td>
<td colspan="1" rowspan="1">5.8 (7/120)</td>
<td colspan="1" rowspan="1">1.7 (1/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 35–44</td>
<td colspan="1" rowspan="1">35.8 (43/120)</td>
<td colspan="1" rowspan="1">25.4 (15/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 45–54</td>
<td colspan="1" rowspan="1">25 (30/120)</td>
<td colspan="1" rowspan="1">47.5 (28/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 55–64</td>
<td colspan="1" rowspan="1">22.5 (27/120)</td>
<td colspan="1" rowspan="1">18.6 (11/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> ≥65</td>
<td colspan="1" rowspan="1">10.8 (13/120)</td>
<td colspan="1" rowspan="1">6.8 (4/59)</td>
</tr>
<tr>
<td colspan="3" rowspan="1">Born city</td>
<td rowspan="20" colspan="1"><strong>0.034</strong></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Aguascalientes</td>
<td colspan="1" rowspan="1">0 (0/120)</td>
<td colspan="1" rowspan="1">1.7 (1/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> CDMX</td>
<td colspan="1" rowspan="1">41.7 (50/120)</td>
<td colspan="1" rowspan="1">30.5 (18/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Chihuahua</td>
<td colspan="1" rowspan="1">0.8 (1/120)</td>
<td colspan="1" rowspan="1">0 (0/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Coahuila</td>
<td colspan="1" rowspan="1">0 (0/120)</td>
<td colspan="1" rowspan="1">1.7 (1/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Guanajuato</td>
<td colspan="1" rowspan="1">0 (0/120)</td>
<td colspan="1" rowspan="1">3.4 (2/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Guerrero</td>
<td colspan="1" rowspan="1">0.8 (1/120)</td>
<td colspan="1" rowspan="1">3.4 (2/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Hidalgo</td>
<td colspan="1" rowspan="1">11.7 (14/120)</td>
<td colspan="1" rowspan="1">3.4 (2/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Jalisco</td>
<td colspan="1" rowspan="1">1.7 (2/120)</td>
<td colspan="1" rowspan="1">0 (0/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> México</td>
<td colspan="1" rowspan="1">23.3 (28/120)</td>
<td colspan="1" rowspan="1">27.1 (16/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Michoacán</td>
<td colspan="1" rowspan="1">5 (6/120)</td>
<td colspan="1" rowspan="1">1.7 (1/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Morelos</td>
<td colspan="1" rowspan="1">2.5 (3/120)</td>
<td colspan="1" rowspan="1">3.4 (2/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Oaxaca</td>
<td colspan="1" rowspan="1">0 (0/120)</td>
<td colspan="1" rowspan="1">5.1 (3/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Puebla</td>
<td colspan="1" rowspan="1">4.2 (5/120)</td>
<td colspan="1" rowspan="1">5.1 (3/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Querétaro</td>
<td colspan="1" rowspan="1">1.7 (2/120)</td>
<td colspan="1" rowspan="1">3.4 (2/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> San Luis Potosí</td>
<td colspan="1" rowspan="1">0 (0/120)</td>
<td colspan="1" rowspan="1">3.4 (2/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Tabasco</td>
<td colspan="1" rowspan="1">0 (0/120)</td>
<td colspan="1" rowspan="1">1.7 (1/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Tlaxcala</td>
<td colspan="1" rowspan="1">3.3 (4/120)</td>
<td colspan="1" rowspan="1">3.4 (2/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Veracruz</td>
<td colspan="1" rowspan="1">2.5 (3/120)</td>
<td colspan="1" rowspan="1">1.7 (1/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Zacatecas</td>
<td colspan="1" rowspan="1">0.8 (1/120)</td>
<td colspan="1" rowspan="1">0 (0/59)</td>
</tr>
<tr>
<td colspan="3" rowspan="1">Patients with CFH</td>
<td rowspan="3" colspan="1"><strong>0.034</strong></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Negative</td>
<td colspan="1" rowspan="1">41.7 (50/120)</td>
<td colspan="1" rowspan="1">25.4 (15/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Positive</td>
<td colspan="1" rowspan="1">58.3 (70/120)</td>
<td colspan="1" rowspan="1">74.6 (44/59)</td>
</tr>
<tr>
<td colspan="3" rowspan="1">Patients with CFH associated with BRCA</td>
<td rowspan="3" colspan="1"><strong>0.015</strong></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> No associated</td>
<td colspan="1" rowspan="1">34.3 (24/70)</td>
<td colspan="1" rowspan="1">13.6 (6/44)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Associated</td>
<td colspan="1" rowspan="1">65.7 (46/70)</td>
<td colspan="1" rowspan="1">86.4 (38/44)</td>
</tr>
<tr><td colspan="4" rowspan="1">Type of cancer reported in CFH patients</td></tr>
<tr>
<td colspan="1" rowspan="1"> Breast</td>
<td colspan="1" rowspan="1">37.1 (26/70)</td>
<td colspan="1" rowspan="1">75 (33/44)</td>
<td colspan="1" rowspan="1"><strong>&lt;0.0001</strong></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Prostate</td>
<td colspan="1" rowspan="1">22.9 (16/70)</td>
<td colspan="1" rowspan="1">13.6 (6/44)</td>
<td colspan="1" rowspan="1">0.225</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Ovarian</td>
<td colspan="1" rowspan="1">8.6 (6/70)</td>
<td colspan="1" rowspan="1">20.5 (9/44)</td>
<td colspan="1" rowspan="1">0.068</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Melanoma</td>
<td colspan="1" rowspan="1">10 (7/70)</td>
<td colspan="1" rowspan="1">9.1 (4/44)</td>
<td colspan="1" rowspan="1">0.873</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Pancreas</td>
<td colspan="1" rowspan="1">8.6 (6/70)</td>
<td colspan="1" rowspan="1">2.3 (1/44)</td>
<td colspan="1" rowspan="1">0.173</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Endometrium</td>
<td colspan="1" rowspan="1">4.3 (3/70)</td>
<td colspan="1" rowspan="1">2.3 (1/44)</td>
<td colspan="1" rowspan="1">0.570</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 1</td>
<td colspan="1" rowspan="1">42.9 (30/70)</td>
<td colspan="1" rowspan="1">54.5 (24/44)</td>
<td rowspan="3" colspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 2</td>
<td colspan="1" rowspan="1">18.6 (13/70)</td>
<td colspan="1" rowspan="1">27.3 (12/44)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 3</td>
<td colspan="1" rowspan="1">4.3 (3/70)</td>
<td colspan="1" rowspan="1">4.5 (2/44)</td>
</tr>
<tr><td colspan="4" rowspan="1">Clinical stage at Dx</td></tr>
<tr>
<td colspan="1" rowspan="1"> IA</td>
<td colspan="1" rowspan="1">5 (6/120)</td>
<td colspan="1" rowspan="1">1.7 (1/59)</td>
<td rowspan="9" colspan="1">0.123</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IC</td>
<td colspan="1" rowspan="1">10 (12/120)</td>
<td colspan="1" rowspan="1">3.4 (2/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IIA</td>
<td colspan="1" rowspan="1">0.8 (1/120)</td>
<td colspan="1" rowspan="1">0 (0/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IIB</td>
<td colspan="1" rowspan="1">0 (0/120)</td>
<td colspan="1" rowspan="1">3.4 (2/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IIIA</td>
<td colspan="1" rowspan="1">5 (6/120)</td>
<td colspan="1" rowspan="1">0 (0/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IIIB</td>
<td colspan="1" rowspan="1">9.2 (11/120)</td>
<td colspan="1" rowspan="1">6.8 (4/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IIIC</td>
<td colspan="1" rowspan="1">44.2 (53/120)</td>
<td colspan="1" rowspan="1">49.2 (29/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IVA</td>
<td colspan="1" rowspan="1">10 (12/120)</td>
<td colspan="1" rowspan="1">15.3 (9/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IVB</td>
<td colspan="1" rowspan="1">15.8 (19/120)</td>
<td colspan="1" rowspan="1">20.3 (12/59)</td>
</tr>
<tr><td colspan="4" rowspan="1">Histological subtype</td></tr>
<tr>
<td colspan="1" rowspan="1"> Clear cells</td>
<td colspan="1" rowspan="1">5 (6/120)</td>
<td colspan="1" rowspan="1">3.4 (2/59)</td>
<td rowspan="14" colspan="1">0.111</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> HGSP</td>
<td colspan="1" rowspan="1">64.2 (77/120)</td>
<td colspan="1" rowspan="1">79.7 (47/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> LGSP</td>
<td colspan="1" rowspan="1">7.5 (9/120)</td>
<td colspan="1" rowspan="1">1.7 (1/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Mucinous</td>
<td colspan="1" rowspan="1">0.8 (1/120)</td>
<td colspan="1" rowspan="1">0 (0/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Endometroid</td>
<td colspan="1" rowspan="1">16.7 (20/120)</td>
<td colspan="1" rowspan="1">5.1 (3/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> G1</td>
<td colspan="1" rowspan="1">15 (3/20)</td>
<td colspan="1" rowspan="1">33.3 (1/3)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> G2</td>
<td colspan="1" rowspan="1">70 (14/20)</td>
<td colspan="1" rowspan="1">66.7 (2/3)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> G3</td>
<td colspan="1" rowspan="1">15 (3/20)</td>
<td colspan="1" rowspan="1">0 (0/3)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Adenocarcinoma</td>
<td colspan="1" rowspan="1">1.7 (2/120)</td>
<td colspan="1" rowspan="1">5.1 (3/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Mixed</td>
<td colspan="1" rowspan="1">4.2 (5/8)</td>
<td colspan="1" rowspan="1">5.1 (3/8)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> HGSP/endometroid</td>
<td colspan="1" rowspan="1">40 (2/5)</td>
<td colspan="1" rowspan="1">100 (3/3)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> HGSP/clear cells</td>
<td colspan="1" rowspan="1">20 (1/5)</td>
<td colspan="1" rowspan="1">0 (0/3)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Endometroid/clear cells</td>
<td colspan="1" rowspan="1">20 (1/5)</td>
<td colspan="1" rowspan="1">0 (0/3)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Endometroid/HGSP</td>
<td colspan="1" rowspan="1">20 (1/5)</td>
<td colspan="1" rowspan="1">0 (0/3)</td>
</tr>
<tr><td colspan="4" rowspan="1">Double primary malignancy</td></tr>
<tr>
<td colspan="1" rowspan="1"> Negative</td>
<td colspan="1" rowspan="1">91.7 (110/120)</td>
<td colspan="1" rowspan="1">76.3 (45/59)</td>
<td rowspan="2" colspan="1"><strong>0.004</strong></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Positive</td>
<td colspan="1" rowspan="1">8.3 (10/120)</td>
<td colspan="1" rowspan="1">23.7 (14/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Breast/ovarian</td>
<td colspan="1" rowspan="1">50 (5/10)</td>
<td colspan="1" rowspan="1">100 (14/14)</td>
<td rowspan="2" colspan="1"><strong>0.003</strong></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Endometrium/ovarian</td>
<td colspan="1" rowspan="1">50 (5/10)</td>
<td colspan="1" rowspan="1">0 (0/14)</td>
</tr>
<tr><td colspan="4" rowspan="1">1° line treatment</td></tr>
<tr>
<td colspan="1" rowspan="1"> CBP/TXL per week</td>
<td colspan="1" rowspan="1">8.3 (10/120)</td>
<td colspan="1" rowspan="1">6.8 (4/59)</td>
<td rowspan="3" colspan="1">0.410</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> CBP/TXL 3 weeks</td>
<td colspan="1" rowspan="1">85.8 (103/120)</td>
<td colspan="1" rowspan="1">91.5 (54/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Other</td>
<td colspan="1" rowspan="1">5.8 (7/120)</td>
<td colspan="1" rowspan="1">1.7 (1/59)</td>
</tr>
<tr><td colspan="4" rowspan="1">Lines of treatment</td></tr>
<tr>
<td colspan="1" rowspan="1"> 1° Line</td>
<td colspan="1" rowspan="1">40 (48/120)</td>
<td colspan="1" rowspan="1">33.9 (20/59)</td>
<td rowspan="3" colspan="1">0.256</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 2° Line</td>
<td colspan="1" rowspan="1">30 (36/120)</td>
<td colspan="1" rowspan="1">23.7 (14/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> ≥3° Line</td>
<td colspan="1" rowspan="1">30 (36/120)</td>
<td colspan="1" rowspan="1">42.4 (25/59)</td>
</tr>
<tr><td colspan="4" rowspan="1">Treatment response at 1° line of Tx</td></tr>
<tr>
<td colspan="1" rowspan="1"> CR</td>
<td colspan="1" rowspan="1">58.3 (70/120)</td>
<td colspan="1" rowspan="1">61 (36/59)</td>
<td rowspan="3" colspan="1">0.375</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> PR</td>
<td colspan="1" rowspan="1">25.8 (31/120)</td>
<td colspan="1" rowspan="1">30.5 (18/59)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> SD</td>
<td colspan="1" rowspan="1">15.8 (19/120)</td>
<td colspan="1" rowspan="1">8.5 (5/59)</td>
</tr>
<tr><td colspan="4" rowspan="1">Platinum-based therapy</td></tr>
<tr>
<td colspan="1" rowspan="1"> Platinum sensitive</td>
<td colspan="1" rowspan="1">93.3 (112/120)</td>
<td colspan="1" rowspan="1">88.1 (52/59)</td>
<td rowspan="2" colspan="1">0.238</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Platinum resistant</td>
<td colspan="1" rowspan="1">6.7 (8/120)</td>
<td colspan="1" rowspan="1">11.9 (7/59)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn4"><p>CFH = cancer family history.</p></div></div></section><p id="p0095">Almost 75% of the patients with BRCA mutations reported CFH in at least one relative (<em>P</em> = 0.034). The most frequently reported CFH type associated with BRCA mutation was breast (<em>P</em> &lt; 0.0001) and we only found a trend for the presence of OC CFH (<em>P</em> = 0.068). Fourteen <em>BRCA</em> positive mutated patient (23.7%) had double primary malignancy (<em>P</em> = 0.004), and all of them were breast/ovarian (<em>P</em> = 0.003) (<a href="#tbl3" class="usa-link">Table 3</a>).</p></section><section id="sec3.6"><h3 class="pmc_sec_title">Clinicopathological Characteristics Associated with BRCA1/2 Mutations</h3>
<p id="p0100">According to <em>BRCA</em> mutations types, <em>BRCA1</em> mutations were more commonly detected in younger patients than in those with <em>BRCA2</em> mutations (median age, 46 vs 54 years; <em>P</em> = 0.001) (<a href="#appsec1" class="usa-link">Supplementary Table 1</a>). The clinicopathological characteristics according to the <em>BRCA1</em> mutation subtypes (Mexican founder mutation vs other <em>BRCA1</em> mutations) analysis showed that all patients with the Mexican founder mutation (11/39) had CFH (<em>P</em> = 0.047) (<a href="#appsec1" class="usa-link">Supplementary Table 2</a>).</p></section><section id="sec3.7"><h3 class="pmc_sec_title">Association of Clinical Characteristics of the Whole Study Population and Recurrence-free Survival</h3>
<p id="p0105">At the time of data cutoff, 123 patients (68.7%) had recurrence disease and 56 patients (31.3%) had no recurrence (both groups were ultimately included in the analysis). The mean follow-up was 41 months (SD 29.7 months) and the median of RFS was 47.7 months [95% CI 40.4–55] for all the patients. Patients with clinical stage I–II had better RFS compared with those with stages IIIA–B, IIIC, IV (96.9 vs 46.3 vs 43.4 vs 41.8 months; <em>P</em> = 0.001). Patients with endometroid histological subtype also had better RFS compared with those with HGSP, clear cell and LGSP (91.8 vs 37.2 vs 40.3 vs 33.8 months; <em>P</em> = 0.004) (<a href="#tbl4" class="usa-link">Table 4</a>).</p>
<section class="tw xbox font-sm" id="tbl4"><h4 class="obj_head">Table 4.</h4>
<div class="caption p"><p>Clinical Characteristics Associated Factors with Recurrence-free Survival</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th rowspan="3" colspan="1">Variable</th>
<th colspan="4" rowspan="1">Total (<em>N</em> = 179)<hr>
</th>
<th colspan="4" rowspan="1">BRCA (−) (<em>N</em> = 120)<hr>
</th>
<th colspan="4" rowspan="1">BRCA (+) (<em>N</em> = 59)<hr>
</th>
</tr>
<tr>
<th rowspan="2" colspan="1">Median</th>
<th colspan="2" rowspan="1">95% Confidence interval<hr>
</th>
<th rowspan="2" colspan="1"><em>P</em></th>
<th rowspan="2" colspan="1">Median</th>
<th colspan="2" rowspan="1">95% Confidence interval<hr>
</th>
<th rowspan="2" colspan="1"><em>P</em></th>
<th rowspan="2" colspan="1">Median</th>
<th colspan="2" rowspan="1">95% Confidence interval<hr>
</th>
<th rowspan="2" colspan="1"><em>P</em></th>
</tr>
<tr>
<th colspan="1" rowspan="1">Lower bound</th>
<th colspan="1" rowspan="1">Upper bound</th>
<th colspan="1" rowspan="1">Lower bound</th>
<th colspan="1" rowspan="1">Upper bound</th>
<th colspan="1" rowspan="1">Lower bound</th>
<th colspan="1" rowspan="1">Upper bound</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">RFS (months)</td>
<td colspan="1" rowspan="1">47.7</td>
<td colspan="1" rowspan="1">40.4</td>
<td colspan="1" rowspan="1">55.0</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">49.2</td>
<td colspan="1" rowspan="1">40.6</td>
<td colspan="1" rowspan="1">57.8</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">43.7</td>
<td colspan="1" rowspan="1">34.8</td>
<td colspan="1" rowspan="1">52.6</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Age (years)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td rowspan="3" colspan="1">0.970</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td rowspan="3" colspan="1">0.818</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td rowspan="3" colspan="1">0.873</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> ≤48</td>
<td colspan="1" rowspan="1">46.3</td>
<td colspan="1" rowspan="1">34.2</td>
<td colspan="1" rowspan="1">58.4</td>
<td colspan="1" rowspan="1">46.3</td>
<td colspan="1" rowspan="1">31.2</td>
<td colspan="1" rowspan="1">61.4</td>
<td colspan="1" rowspan="1">46.5</td>
<td colspan="1" rowspan="1">20.1</td>
<td colspan="1" rowspan="1">72.9</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> &gt;48</td>
<td colspan="1" rowspan="1">48.1</td>
<td colspan="1" rowspan="1">39.9</td>
<td colspan="1" rowspan="1">56.2</td>
<td colspan="1" rowspan="1">51.4</td>
<td colspan="1" rowspan="1">30.9</td>
<td colspan="1" rowspan="1">72.0</td>
<td colspan="1" rowspan="1">41.8</td>
<td colspan="1" rowspan="1">33.1</td>
<td colspan="1" rowspan="1">50.5</td>
</tr>
<tr>
<td colspan="4" rowspan="1">Group of age at DX</td>
<td rowspan="6" colspan="1"><strong>&lt;0.0001</strong></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td rowspan="6" colspan="1"><strong>&lt;0.0001</strong></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td rowspan="6" colspan="1"><strong>&lt;0.0001</strong></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> ≤34</td>
<td colspan="1" rowspan="1">14.7</td>
<td colspan="1" rowspan="1">7.4</td>
<td colspan="1" rowspan="1">22.1</td>
<td colspan="1" rowspan="1">16.3</td>
<td colspan="1" rowspan="1">12.3</td>
<td colspan="1" rowspan="1">20.2</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 35–44</td>
<td colspan="1" rowspan="1">51.7</td>
<td colspan="1" rowspan="1">42.5</td>
<td colspan="1" rowspan="1">61.0</td>
<td colspan="1" rowspan="1">51.8</td>
<td colspan="1" rowspan="1">31.7</td>
<td colspan="1" rowspan="1">72.0</td>
<td colspan="1" rowspan="1">46.5</td>
<td colspan="1" rowspan="1">20.5</td>
<td colspan="1" rowspan="1">72.5</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 45–54</td>
<td colspan="1" rowspan="1">49.0</td>
<td colspan="1" rowspan="1">29.1</td>
<td colspan="1" rowspan="1">68.9</td>
<td colspan="1" rowspan="1">57.7</td>
<td colspan="1" rowspan="1">34.6</td>
<td colspan="1" rowspan="1">80.8</td>
<td colspan="1" rowspan="1">47.7</td>
<td colspan="1" rowspan="1">34.7</td>
<td colspan="1" rowspan="1">60.7</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 55–64</td>
<td colspan="1" rowspan="1">61.4</td>
<td colspan="1" rowspan="1">32.3</td>
<td colspan="1" rowspan="1">90.4</td>
<td colspan="1" rowspan="1">51.4</td>
<td colspan="1" rowspan="1">25.0</td>
<td colspan="1" rowspan="1">77.9</td>
<td colspan="1" rowspan="1">37.2</td>
<td colspan="1" rowspan="1">0.0</td>
<td colspan="1" rowspan="1">85.1</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> ≥65</td>
<td colspan="1" rowspan="1">43.7</td>
<td colspan="1" rowspan="1">20.7</td>
<td colspan="1" rowspan="1">66.7</td>
<td colspan="1" rowspan="1">30.4</td>
<td colspan="1" rowspan="1">22.8</td>
<td colspan="1" rowspan="1">69.2</td>
<td colspan="1" rowspan="1">56.6</td>
<td colspan="1" rowspan="1">36.0</td>
<td colspan="1" rowspan="1">77.2</td>
</tr>
<tr>
<td colspan="4" rowspan="1">Clinical stage at Dx</td>
<td rowspan="5" colspan="1"><strong>0.001</strong></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td rowspan="5" colspan="1"><strong>0.001</strong></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td rowspan="5" colspan="1">0.199</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> I &amp; II</td>
<td colspan="1" rowspan="1">96.9</td>
<td colspan="1" rowspan="1">86.6</td>
<td colspan="1" rowspan="1">107.3</td>
<td colspan="1" rowspan="1">96.9</td>
<td colspan="1" rowspan="1">86.5</td>
<td colspan="1" rowspan="1">107.3</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">NR</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> III (A &amp; B)</td>
<td colspan="1" rowspan="1">46.3</td>
<td colspan="1" rowspan="1">21.2</td>
<td colspan="1" rowspan="1">71.4</td>
<td colspan="1" rowspan="1">38.4</td>
<td colspan="1" rowspan="1">16.8</td>
<td colspan="1" rowspan="1">60.0</td>
<td colspan="1" rowspan="1">59.6</td>
<td colspan="1" rowspan="1">5.4</td>
<td colspan="1" rowspan="1">113.8</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IIIC</td>
<td colspan="1" rowspan="1">43.4</td>
<td colspan="1" rowspan="1">28.5</td>
<td colspan="1" rowspan="1">58.2</td>
<td colspan="1" rowspan="1">50.8</td>
<td colspan="1" rowspan="1">37.7</td>
<td colspan="1" rowspan="1">63.9</td>
<td colspan="1" rowspan="1">37.2</td>
<td colspan="1" rowspan="1">23.2</td>
<td colspan="1" rowspan="1">51.1</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IV</td>
<td colspan="1" rowspan="1">41.8</td>
<td colspan="1" rowspan="1">23.9</td>
<td colspan="1" rowspan="1">59.6</td>
<td colspan="1" rowspan="1">28.5</td>
<td colspan="1" rowspan="1">8.2</td>
<td colspan="1" rowspan="1">48.9</td>
<td colspan="1" rowspan="1">43.7</td>
<td colspan="1" rowspan="1">34.4</td>
<td colspan="1" rowspan="1">49.2</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Histology</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td rowspan="7" colspan="1"><strong>0.004</strong></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td rowspan="7" colspan="1"><strong>0.004</strong></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td rowspan="7" colspan="1"><strong>&lt;0.0001</strong></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Clear cells</td>
<td colspan="1" rowspan="1">40.3</td>
<td colspan="1" rowspan="1">26.7</td>
<td colspan="1" rowspan="1">53.8</td>
<td colspan="1" rowspan="1">40.3</td>
<td colspan="1" rowspan="1">26.5</td>
<td colspan="1" rowspan="1">54.1</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> HGSP</td>
<td colspan="1" rowspan="1">37.2</td>
<td colspan="1" rowspan="1">27.0</td>
<td colspan="1" rowspan="1">47.3</td>
<td colspan="1" rowspan="1">33.4</td>
<td colspan="1" rowspan="1">19.4</td>
<td colspan="1" rowspan="1">47.5</td>
<td colspan="1" rowspan="1">40.1</td>
<td colspan="1" rowspan="1">30.7</td>
<td colspan="1" rowspan="1">49.5</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> LGSP</td>
<td colspan="1" rowspan="1">33.8</td>
<td colspan="1" rowspan="1">28.5</td>
<td colspan="1" rowspan="1">84.6</td>
<td colspan="1" rowspan="1">62.5</td>
<td colspan="1" rowspan="1">16.3</td>
<td colspan="1" rowspan="1">132.3</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Endometroid</td>
<td colspan="1" rowspan="1">91.8</td>
<td colspan="1" rowspan="1">50.7</td>
<td colspan="1" rowspan="1">132.8</td>
<td colspan="1" rowspan="1">96.9</td>
<td colspan="1" rowspan="1">86.2</td>
<td colspan="1" rowspan="1">107.6</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Adenocarcinoma</td>
<td colspan="1" rowspan="1">88.1</td>
<td colspan="1" rowspan="1">69.7</td>
<td colspan="1" rowspan="1">106.5</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">79.5</td>
<td colspan="1" rowspan="1">29.2</td>
<td colspan="1" rowspan="1">129.8</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Mixed</td>
<td colspan="1" rowspan="1">54.5</td>
<td colspan="1" rowspan="1">33.6</td>
<td colspan="1" rowspan="1">75.4</td>
<td colspan="1" rowspan="1">102.9</td>
<td colspan="1" rowspan="1">43.6</td>
<td colspan="1" rowspan="1">110.9</td>
<td colspan="1" rowspan="1">54.5</td>
<td colspan="1" rowspan="1">37.2</td>
<td colspan="1" rowspan="1">71.9</td>
</tr>
<tr>
<td colspan="4" rowspan="1">Double primary malignancy</td>
<td rowspan="3" colspan="1">0.887</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td rowspan="3" colspan="1">0.720</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td rowspan="3" colspan="1">0.897</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Negative</td>
<td colspan="1" rowspan="1">47.7</td>
<td colspan="1" rowspan="1">40.4</td>
<td colspan="1" rowspan="1">54.9</td>
<td colspan="1" rowspan="1">49.2</td>
<td colspan="1" rowspan="1">41.4</td>
<td colspan="1" rowspan="1">57.0</td>
<td colspan="1" rowspan="1">43.7</td>
<td colspan="1" rowspan="1">35.0</td>
<td colspan="1" rowspan="1">52.3</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Positive</td>
<td colspan="1" rowspan="1">80.6</td>
<td colspan="1" rowspan="1">11.6</td>
<td colspan="1" rowspan="1">149.5</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">34.5</td>
<td colspan="1" rowspan="1">29.2</td>
<td colspan="1" rowspan="1">96.0</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Breast/ovarian</td>
<td colspan="1" rowspan="1">34.5</td>
<td colspan="1" rowspan="1">4.7</td>
<td colspan="1" rowspan="1">93.5</td>
<td rowspan="2" colspan="1">0.868</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">NR</td>
<td rowspan="2" colspan="1">–</td>
<td colspan="1" rowspan="1">34.5</td>
<td colspan="1" rowspan="1">29.2</td>
<td colspan="1" rowspan="1">96.0</td>
<td rowspan="2" colspan="1">–</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Endometrium/ovarian</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td colspan="1" rowspan="1">1° line treatment</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td rowspan="4" colspan="1">0.793</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td rowspan="4" colspan="1">0.875</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td rowspan="4" colspan="1">0.937</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> CBP/TXL per week</td>
<td colspan="1" rowspan="1">42.8</td>
<td colspan="1" rowspan="1">32.5</td>
<td colspan="1" rowspan="1">53.1</td>
<td colspan="1" rowspan="1">42.8</td>
<td colspan="1" rowspan="1">3.4</td>
<td colspan="1" rowspan="1">49.4</td>
<td colspan="1" rowspan="1">40.1</td>
<td colspan="1" rowspan="1">9.2</td>
<td colspan="1" rowspan="1">71.0</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> CBP/TXL 3 weeks</td>
<td colspan="1" rowspan="1">46.5</td>
<td colspan="1" rowspan="1">37.5</td>
<td colspan="1" rowspan="1">55.4</td>
<td colspan="1" rowspan="1">49.2</td>
<td colspan="1" rowspan="1">6.3</td>
<td colspan="1" rowspan="1">61.6</td>
<td colspan="1" rowspan="1">43.7</td>
<td colspan="1" rowspan="1">32.3</td>
<td colspan="1" rowspan="1">55.1</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Other</td>
<td colspan="1" rowspan="1">61.4</td>
<td colspan="1" rowspan="1">9.2</td>
<td colspan="1" rowspan="1">113.5</td>
<td colspan="1" rowspan="1">61.4</td>
<td colspan="1" rowspan="1">26.6</td>
<td colspan="1" rowspan="1">113.5</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Line of treatment</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td rowspan="4" colspan="1"><strong>0.043</strong></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td rowspan="4" colspan="1"><strong>0.023</strong></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td rowspan="4" colspan="1">0.659</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 1° Line</td>
<td colspan="1" rowspan="1">62.3</td>
<td colspan="1" rowspan="1">49.8</td>
<td colspan="1" rowspan="1">74.9</td>
<td colspan="1" rowspan="1">62.5</td>
<td colspan="1" rowspan="1">48.6</td>
<td colspan="1" rowspan="1">76.4</td>
<td colspan="1" rowspan="1">34.5</td>
<td colspan="1" rowspan="1">21.0</td>
<td colspan="1" rowspan="1">48.0</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 2° Line</td>
<td colspan="1" rowspan="1">47.7</td>
<td colspan="1" rowspan="1">37.9</td>
<td colspan="1" rowspan="1">57.4</td>
<td colspan="1" rowspan="1">46.3</td>
<td colspan="1" rowspan="1">23.0</td>
<td colspan="1" rowspan="1">69.6</td>
<td colspan="1" rowspan="1">43.4</td>
<td colspan="1" rowspan="1">20.9</td>
<td colspan="1" rowspan="1">65.9</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> ≥3° Line</td>
<td colspan="1" rowspan="1">37.6</td>
<td colspan="1" rowspan="1">30.02</td>
<td colspan="1" rowspan="1">45.21</td>
<td colspan="1" rowspan="1">33.8</td>
<td colspan="1" rowspan="1">20.8</td>
<td colspan="1" rowspan="1">46.8</td>
<td colspan="1" rowspan="1">47.7</td>
<td colspan="1" rowspan="1">30.0</td>
<td colspan="1" rowspan="1">65.4</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn5"><p>CHF = cancer family history.</p></div></div></section></section><section id="sec3.8"><h3 class="pmc_sec_title">RFS Analysis According to BRCA1/2 Status</h3>
<p id="p0110">In <em>BRCA1/2</em> mutated patients (59/179), there was a trend toward a better RFS in those patients without CFH compared with those with CFH (56.6 [44.1–69.1] vs 37.6 [28.4–46.9]; <em>P</em> = 0.096). There was no significant difference in RFS between <em>BRCA</em> mutated carriers and no mutation carriers (wild-type patients) (<em>P</em> = 0.949) (<a href="#tbl5" class="usa-link">Table 5</a>, <a href="#fig2" class="usa-link">Figure 2</a>A), but <em>BRCA1</em> mutated patients group did show a worse RFS than its counterpart of patients with <em>BRCA2</em> mutation (37.6 [29–46.2] vs 72.8 [38.4–107.2]; <em>P</em> = 0.030) (<a href="#tbl5" class="usa-link">Table 5</a>, <a href="#fig2" class="usa-link">Figure 2</a>B). Particularly, in the <em>BRCA1</em> patient subpopulation, the specific mutation <em>ex9-12del</em> (Mexican founder mutation) showed a better RFS than those with other types of <em>BRCA1</em> mutations (86.1 [37.2–135.1] vs 34.5 [20.7–48.2]; <em>P</em> = 0.033) (<a href="#fig2" class="usa-link">Figure 2</a>C).</p>
<section class="tw xbox font-sm" id="tbl5"><h4 class="obj_head">Table 5.</h4>
<div class="caption p"><p>BRCA Mutations Associated Factors with Recurrence-free Survival</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th rowspan="2" colspan="1">Variable</th>
<th rowspan="2" colspan="1"><em>N</em></th>
<th rowspan="2" colspan="1">Median</th>
<th colspan="2" rowspan="1">95% Confidence interval<hr>
</th>
<th rowspan="2" colspan="1"><em>P</em></th>
</tr>
<tr>
<th colspan="1" rowspan="1">Lower bound</th>
<th colspan="1" rowspan="1">Upper bound</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">RFS (months)</td>
<td colspan="1" rowspan="1">179</td>
<td colspan="1" rowspan="1">47.7</td>
<td colspan="1" rowspan="1">40.4</td>
<td colspan="1" rowspan="1">55.0</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="5" rowspan="1">BRCA status</td>
<td rowspan="3" colspan="1">0.949</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> WT</td>
<td colspan="1" rowspan="1">120</td>
<td colspan="1" rowspan="1">49.2</td>
<td colspan="1" rowspan="1">41.59</td>
<td colspan="1" rowspan="1">56.8</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Mutated</td>
<td colspan="1" rowspan="1">59</td>
<td colspan="1" rowspan="1">43.7</td>
<td colspan="1" rowspan="1">34.8</td>
<td colspan="1" rowspan="1">52.6</td>
</tr>
<tr>
<td colspan="5" rowspan="1">Type of BRCA mut</td>
<td rowspan="3" colspan="1"><strong>0.030</strong></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> BRCA1</td>
<td colspan="1" rowspan="1">39</td>
<td colspan="1" rowspan="1">37.6</td>
<td colspan="1" rowspan="1">29.0</td>
<td colspan="1" rowspan="1">46.2</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> BRCA2</td>
<td colspan="1" rowspan="1">20</td>
<td colspan="1" rowspan="1">72.77</td>
<td colspan="1" rowspan="1">38.37</td>
<td colspan="1" rowspan="1">107.17</td>
</tr>
<tr>
<td colspan="5" rowspan="1">BRCA location</td>
<td rowspan="4" colspan="1">0.080</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> OCCR</td>
<td colspan="1" rowspan="1">30</td>
<td colspan="1" rowspan="1">41.8</td>
<td colspan="1" rowspan="1">19.5</td>
<td colspan="1" rowspan="1">64.0</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> BCCR</td>
<td colspan="1" rowspan="1">16</td>
<td colspan="1" rowspan="1">72.8</td>
<td colspan="1" rowspan="1">27.5</td>
<td colspan="1" rowspan="1">118.1</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> NRR</td>
<td colspan="1" rowspan="1">13</td>
<td colspan="1" rowspan="1">40.1</td>
<td colspan="1" rowspan="1">19.4</td>
<td colspan="1" rowspan="1">60.7</td>
</tr>
<tr>
<td colspan="5" rowspan="1">Type of BRCA1 mut</td>
<td rowspan="3" colspan="1"><strong>0.033</strong></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Endemic (exon 9–12 del)</td>
<td colspan="1" rowspan="1">11</td>
<td colspan="1" rowspan="1">86.1</td>
<td colspan="1" rowspan="1">37.2</td>
<td colspan="1" rowspan="1">135.1</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Other</td>
<td colspan="1" rowspan="1">28</td>
<td colspan="1" rowspan="1">34.5</td>
<td colspan="1" rowspan="1">20.7</td>
<td colspan="1" rowspan="1">48.2</td>
</tr>
<tr>
<td colspan="5" rowspan="1">Type of BRCA2 mut</td>
<td rowspan="3" colspan="1">0.442</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> c.8168 A &gt; G</td>
<td colspan="1" rowspan="1">5</td>
<td colspan="1" rowspan="1">72.8</td>
<td colspan="1" rowspan="1">51.9</td>
<td colspan="1" rowspan="1">93.6</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Other</td>
<td colspan="1" rowspan="1">15</td>
<td colspan="1" rowspan="1">62.3</td>
<td colspan="1" rowspan="1">19.2</td>
<td colspan="1" rowspan="1">105.3</td>
</tr>
<tr>
<td colspan="5" rowspan="1">BRCA1 location</td>
<td rowspan="4" colspan="1">0.584</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> OCCR</td>
<td colspan="1" rowspan="1">22</td>
<td colspan="1" rowspan="1">27.4</td>
<td colspan="1" rowspan="1">4.4</td>
<td colspan="1" rowspan="1">50.5</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> BCCR</td>
<td colspan="1" rowspan="1">9</td>
<td colspan="1" rowspan="1">79.5</td>
<td colspan="1" rowspan="1">39.1</td>
<td colspan="1" rowspan="1">119.9</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> NRR</td>
<td colspan="1" rowspan="1">8</td>
<td colspan="1" rowspan="1">40.1</td>
<td colspan="1" rowspan="1">25.7</td>
<td colspan="1" rowspan="1">54.4</td>
</tr>
<tr>
<td colspan="5" rowspan="1">BRCA2 location</td>
<td rowspan="4" colspan="1"><strong>0.013</strong></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> OCCR</td>
<td colspan="1" rowspan="1">8</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">NR</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> BCCR</td>
<td colspan="1" rowspan="1">7</td>
<td colspan="1" rowspan="1">72.8</td>
<td colspan="1" rowspan="1">39.0</td>
<td colspan="1" rowspan="1">106.6</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> NRR</td>
<td colspan="1" rowspan="1">5</td>
<td colspan="1" rowspan="1">25.8</td>
<td colspan="1" rowspan="1">8.3</td>
<td colspan="1" rowspan="1">43.2</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn6"><p>OCCR = ovarian cancer cluster region; BCCR = breast cancer cluster region; NRR = not-related risk.</p></div></div></section><figure class="fig xbox font-sm" id="fig2" title="Figure 2"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6931216_gr2.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8177/6931216/12ab6d84acf0/gr2.jpg" loading="lazy" height="906" width="745" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>Impact of BRCA mutations on recurrence-free survival of Mexican ovarian cancer patients.</strong> (A) RFS of patients with BRCA wild-type (blue line) vs mutated BRCA (green line) (49.2 [41.6–56.8] vs 43.7 [34.8–52.6] <em>P</em> = 0.949). (B) RFS compared between <em>BRCA1</em> mutations carriers (blue line) vs <em>BRCA2</em> mutations carriers (green line) (37.6 [29–46.2] vs 72.8 [38.4–107.2]; <em>P</em> = 0.030). (C) <em>BRCA1</em> mutation carriers, comparing survival between carriers of the Mexican founder mutation <em>(ex9-12del)</em> (purple line) vs other mutations in <em>BRCA1</em> (blue line) (86.1 [37.2–135.1] vs 12.0, 95% C.I. [11.7–12.3]; <em>P</em> = 0.033). (D) RFS comparison in <em>BRCA</em> OCCR (violet line), BCCR (purple line), and NRR (green line) (41.6 [19.5–64.0] vs 72.8 [27.5–118.0] vs 40.1 [19.4–60.7]; <em>P</em> = 0.155). (E) RFS comparison of <em>BRCA1</em> locations: OCCR (violet line), BCCR (purple line) and NRR (green line) (27.4 [5.9–48.8] vs 79.5 [39.1–119.9] vs 40.1 [25.7–54.4]; <em>P</em> = 0.611). (F) RFS <em>BRCA2</em> locations: OCCR (violet line), BCCR (purple line) and NRR (green line); (NR vs 72.8 [39–106.6] vs 25.8 [8.3–43.2]; <em>P</em> = 0.013). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)</p></figcaption></figure></section><section id="sec3.9"><h3 class="pmc_sec_title">RFS Depending on the Location of BRCA1/2 Mutation</h3>
<p id="p0115">The analysis considering the location of the mutations globally in the OCCR, BCCR and NRR regions, showed a superior benefit on RFS for those mutations located in BCCR (41.6 [19.5–64.0] vs 72.8 [27.5–118.0] vs 40.1 [19.4–60.7]; <em>P</em> = 0.155; <a href="#fig1" class="usa-link">Figure 1</a>D). RFS analysis of <em>BRCA1</em> mutated subpopulation when classified by mutation location (OCCR, BCCR, NRR) do not shown differences (27.4 [5.9–48.8] vs 79.5 [39.1–119.9] vs 40.1 [25.7–54.4]; <em>P</em> = 0.611) (<a href="#tbl5" class="usa-link">Table 5</a>, <a href="#fig2" class="usa-link">Figure 2</a>E). In contrast, the RFS analysis of mutation locations for <em>BRCA2</em> has shown a better RFS to OCCR than those with mutations in BCCR and NRR (NR vs 72.8 [39–106.6] vs 25.8 [8.3–43.2]; <em>P</em> = 0.013) (<a href="#tbl5" class="usa-link">Table 5</a>, <a href="#fig2" class="usa-link">Figure 2</a>F).</p>
<p id="p0120">Multivariate analysis showed that <em>BRCA2</em>-mutated OC patients are likely to have better RFS than those with <em>BRCA1</em> mutations (HR = 0.426; <em>P</em> = 0.035) and patients with a <em>BRCA1</em> mutation other than ex9-12del (Mexican founder mutation) have a higher recurrence risk (HR = 3.07; <em>P</em> = 0.042).</p></section></section><section id="sec4"><h2 class="pmc_sec_title">Discussion</h2>
<p id="p0125"><em>BRCA</em> genes are important elements in the suppression of tumors <a href="#bib13" class="usa-link" aria-describedby="bib13">[13]</a>. In neoplasms such as breast and ovarian cancer, mutation of <em>BRCA1</em>/<em>2</em> genes is linked to the hereditary development of diseases <a href="#bib14" class="usa-link" aria-describedby="bib14">[14]</a>. Analysis of <em>BRCA</em> status has quickly become a standard clinical test in OC in developed countries. Benefit is being reflected in risk determination and appropriate treatment decisions <a href="#bib15" class="usa-link" aria-describedby="bib15">[15]</a>. The NCCN has concentrated a series of guidelines to be used in the assessment and evaluation of genetic risk. The Society of Gynecologic Oncology (SGO) and the American College of Obstetricians and Gynecologists have joined in a consensus statement regarding genetic counseling as well <a href="#bib16" class="usa-link" aria-describedby="bib16">[16]</a>. According to these guidelines, all women diagnosed with OC are advised to receive genetic counseling and testing for germline <em>BRCA</em> mutations.</p>
<p id="p0130">Integrated models of close collaborations between geneticists and oncologists has allowed the exploration of BRCA and other OC-associated genes <a href="#bib17" class="usa-link" aria-describedby="bib17">[17]</a>, but despite the clinical importance of germline <em>BRCA</em> mutations, widespread use of genetic testing is still low in some regions of the world.</p>
<p id="p0135">This work is the largest analysis of <em>BRCA</em> genes status in a Mexican OC population.</p>
<p id="p0140">Frequency of <em>BRCA1/2</em> mutations was considerably higher than previously reported by studies in other predominantly Caucasian population studies <a href="#bib7" class="usa-link" aria-describedby="bib7">[7]</a>. In the same way, our study reported a higher frequency of BRCA mutations carriers than a cohort of Hispanic cancer patients with breast and ovarian cancer <a href="#bib3" class="usa-link" aria-describedby="bib3">[3]</a>.</p>
<p id="p0145">In our study, most of the mutations were located in the central regions of both genes. The OCCR and BCCR regions were characterized as risk regions for developing ovarian and breast cancer, respectively. For the <em>BRCA1</em> gene, it was determined that the mutations that occurred between exons 1–11, and particularly in the central region of exon 11, conferred an elevated risk of OC compared with the mutations present in exons 12–24. It was also observed that mutations in the OCCR region decreased the risk of breast cancer and increased the risk of OC <a href="#bib18" class="usa-link" aria-describedby="bib18">[18]</a>, <a href="#bib19" class="usa-link" aria-describedby="bib19">[19]</a>. Similarly, for the <em>BRCA2</em> gene, it was observed that the mutations in exon 11 confer an increased risk of OC compared with a lower risk of breast cancer <a href="#bib19" class="usa-link" aria-describedby="bib19">[19]</a>, <a href="#bib20" class="usa-link" aria-describedby="bib20">[20]</a>. The advance in the study of mutations in the BRCA genes has made it possible to elucidate new regions OCCR and BCCR, which amplifies the inclusion of mutations in new regions now proven to contribute to the risk of OC and breast cancer <a href="#bib21" class="usa-link" aria-describedby="bib21">[21]</a>.</p>
<p id="p0150">Among BRCA1 mutations, those located in OCCR regions represented a higher percentage than mutations in BCCR and mutations in NRR regions. For BRCA2, half of the mutations were located in OCCR regions; however, mutations in BCCR occurred less frequently than mutations in NRR regions. It should be mentioned that in the present work were found OCCR and BCCR regions mutations that were not previously reported, which indicates that these mutations can be part of the characteristic mutations of carrier patients with OC.</p>
<p id="p0155">The possible effect that a certain mutation may have on the risk of cancer is of clinical significance. Among the mutations detected in our study, we observed the predominance of pathogenic variants in both <em>BRCA1</em>/<em>2</em>. This finding represents more than double than the observed in a study of 333 nonselected cases of OC in a Polish population <a href="#bib22" class="usa-link" aria-describedby="bib22">[22]</a>. Another study that included 158 nonselected Brazilian OC patients identified a proportion of BRCA1 pathogenic variants similar to our study <a href="#bib23" class="usa-link" aria-describedby="bib23">[23]</a>.</p>
<p id="p0160">Almost 75% of the patients with mutations in a <em>BRCA</em> gene had a CFH and most of these cases were related to breast cancer. This data could serve to support the recommendation of providing genetic counseling to OC patients. The risk of OC in <em>BRCA1/2</em> mutation carriers considering the position of the mutation has been previously analyzed. In some studies, mutations in OCCR and BCCR were found to be associated with a higher incidence of OC compared with the incidence of breast cancer <a href="#bib19" class="usa-link" aria-describedby="bib19">[19]</a>; in addition, it has been found a slightly lower association between CFH and the risk of OC compared with the correlation analysis performed independently of the cluster regions for OCCR <a href="#bib24" class="usa-link" aria-describedby="bib24">[24]</a>.</p>
<p id="p0165">Several studies have reported that the presence of mutations in <em>BRCA</em> genes correlates with better survival in patients with OC <a href="#bib5" class="usa-link" aria-describedby="bib5">[5]</a>, <a href="#bib25" class="usa-link" aria-describedby="bib25">[25]</a>. This finding may correspond to a better response to chemotherapy treatment <a href="#bib26" class="usa-link" aria-describedby="bib26">[26]</a>, <a href="#bib27" class="usa-link" aria-describedby="bib27">[27]</a>, which becomes more successful because of deficiency in the mechanisms of damage repair to DNA in which <em>BRCA1/2</em> are involved <a href="#bib28" class="usa-link" aria-describedby="bib28">[28]</a>, <a href="#bib29" class="usa-link" aria-describedby="bib29">[29]</a>, <a href="#bib30" class="usa-link" aria-describedby="bib30">[30]</a>.</p>
<p id="p0170">Our results do not show a significant difference in survival analyses between <em>BRCA</em> mutated and wild-type carriers. In this context, a study of 1421 OC patients showed an initial survival advantage among BRCA mutation carriers, but this response did not predict long-term (10 years) survival) <a href="#bib31" class="usa-link" aria-describedby="bib31">[31]</a>. Also, another study that analyzed the survival of OC patients carrying germline mutations in the <em>BRCA1/2</em> genes compared with survival of patients with strong family history for breast or ovarian cancer and with a negative genetic testing for <em>BRCA</em> mutation showed no survival advantage for <em>BRCA</em> mutation carrier patients <a href="#bib32" class="usa-link" aria-describedby="bib32">[32]</a>.</p>
<p id="p0175">In our study population, the RFS analysis between <em>BRCA1</em> mutation and <em>BRCA2</em> mutation carriers detected a better prognosis for those with the <em>BRCA2</em> mutation. This finding is consistent with previous reports <a href="#bib33" class="usa-link" aria-describedby="bib33">[33]</a>.</p>
<p id="p0180">Finally, we observed a <em>BRCA1 ex9-12del</em> prevalence of 28.2% (11/39) as well as an association with a better RFS compared with RFS of other mutations in <em>BRCA1</em>. The Mexican founder mutation <em>BRCA1 ex9-12del</em> was first detected in 2013, in a study that sought to analyze the prevalence and types of mutations in BRCA. In that study, 46 Hispanic patients with a personal or familial history of ovarian and breast cancer were included. A subpopulation of 492 breast cancer patients was analyzed to characterize the large rearrangements of <em>BRCA1 ex9-12del</em>. This analysis found that this mutation accounted for 10–12% of all mutations in <em>BRCA1</em>
<a href="#bib33" class="usa-link" aria-describedby="bib33">[33]</a>. On the other hand, a study by Garza-Villarreal included 92 patients with ovarian cancer found that the prevalence of Mexican founder mutation was 35% (considering all BRCA mutated OC patients) <a href="#bib3" class="usa-link" aria-describedby="bib3">[3]</a>. The difference in the prevalence of the <em>BRCA1 ex9-12del</em> mutation compared with the reported in our study (39.1% vs 28.2%) may be because of the methodological characteristics of both studies. The association of <em>BRCA1 ex9-12del</em> mutation with a better RFS may be because of the biological effect of the deletion, which causes the loss of a vast extension of thousands of base pairs of nucleotides in the <em>BRCA1</em> gene <a href="#bib34" class="usa-link" aria-describedby="bib34">[34]</a>, generating a truncated and less functional form of the protein compared with those generated by other mutations that give rise to not so radical changes <a href="#bib34" class="usa-link" aria-describedby="bib34">[34]</a>. The association of Mexican founder mutation and better RFS rate could result in a very useful tool in genetic counseling to predict the prognosis of OC in patients with this specific mutation.</p>
<p id="p0185">In conclusion, this study reports the highest prevalence of BRCA1/2 mutations in an OC patient population. Patients with mutations in <em>BRCA2</em> have a better prognosis than those mutated in <em>BRCA1</em>. The Mexican founder mutation, <em>BRCA1</em> ex9-12del, has an important role in the clinical outcomes. These results highlight the importance to test all the OC patients with CFH and HGSP histology in to integrate into the national health system as a diagnostic test.</p></section><section id="sec5"><h2 class="pmc_sec_title">Conflict of Interest</h2>
<p id="p0190">DGR, RMAG, and GAG have participated in Speakers' Bureau to AstraZeneca. DGR also has participated as speaker with Roche and Lilly. The other authors have no conflicts of interest to declare.</p></section><section id="ack0010" class="ack"><h2 class="pmc_sec_title">Acknowledgments/Funding Source</h2>
<p>The authors sincerely thank Paulina Maria Núñez-Martinez for the revision and comments made to this manuscript, and they also thank Ernesto González-Ibarra for all his technical support. Astra Zeneca supported this work.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="appsec2">
<sup>Appendix A</sup><p class="display-inline" id="p0205">Supplementary data to this article can be found online at <a href="https://doi.org/10.1016/j.tranon.2019.11.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.1016/j.tranon.2019.11.003</a>.</p>
</div></div></section><section id="appsec1"><h2 class="pmc_sec_title">Appendix A. Supplementary data</h2>
<p id="p0200">The following are the Supplementary data to this article:</p>
<section class="sm xbox font-sm" id="mmc1"><div class="caption p"><span>Multimedia component 1</span></div>
<div class="media p" title="Multimedia component 1"><div class="caption">
<a href="/articles/instance/6931216/bin/mmc1.xml" data-ga-action="click_feat_suppl" class="usa-link">mmc1.xml</a><sup> (255B, xml) </sup>
</div></div></section><section class="sm xbox font-sm" id="mmc2"><div class="caption p"><span>Multimedia component 2</span></div>
<div class="media p" title="Multimedia component 2"><div class="caption">
<a href="/articles/instance/6931216/bin/mmc2.docx" data-ga-action="click_feat_suppl" class="usa-link">mmc2.docx</a><sup> (34.9KB, docx) </sup>
</div></div></section></section><section id="cebib0010" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="cebib0010_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="bib1">
<span class="label">1.</span><cite>Jones M.R., Kamara D., Karlan B.Y., Pharoah P.D.P., Gayther S.A. Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction. Gynecol Oncol. 2017;147(3):705–713. doi: 10.1016/j.ygyno.2017.10.001.</cite> [<a href="https://doi.org/10.1016/j.ygyno.2017.10.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29054568/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gynecol%20Oncol&amp;title=Genetic%20epidemiology%20of%20ovarian%20cancer%20and%20prospects%20for%20polygenic%20risk%20prediction&amp;author=M.R.%20Jones&amp;author=D.%20Kamara&amp;author=B.Y.%20Karlan&amp;author=P.D.P.%20Pharoah&amp;author=S.A.%20Gayther&amp;volume=147&amp;issue=3&amp;publication_year=2017&amp;pages=705-713&amp;pmid=29054568&amp;doi=10.1016/j.ygyno.2017.10.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib2">
<span class="label">2.</span><cite>Kerber R.A., Slattery M.L. The impact of family history on ovarian cancer risk. The Utah Population Database. Arch Intern Med. 1995;155(9):905–912.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/7726698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch%20Intern%20Med&amp;title=The%20impact%20of%20family%20history%20on%20ovarian%20cancer%20risk.%20The%20Utah%20Population%20Database&amp;author=R.A.%20Kerber&amp;author=M.L.%20Slattery&amp;volume=155&amp;issue=9&amp;publication_year=1995&amp;pages=905-912&amp;pmid=7726698&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib3">
<span class="label">3.</span><cite>Villarreal-Garza C., Alvarez-Gomez R.M., Perez-Plasencia C., Herrera L.A., Herzog J., Castillo D. Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico. Cancer. 2015;121(3):372–378. doi: 10.1002/cncr.29058.</cite> [<a href="https://doi.org/10.1002/cncr.29058" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4304938/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25236687/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Significant%20clinical%20impact%20of%20recurrent%20BRCA1%20and%20BRCA2%20mutations%20in%20Mexico&amp;author=C.%20Villarreal-Garza&amp;author=R.M.%20Alvarez-Gomez&amp;author=C.%20Perez-Plasencia&amp;author=L.A.%20Herrera&amp;author=J.%20Herzog&amp;volume=121&amp;issue=3&amp;publication_year=2015&amp;pages=372-378&amp;pmid=25236687&amp;doi=10.1002/cncr.29058&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib4">
<span class="label">4.</span><cite>Zheng G., Yu H., Kanerva A., Forsti A., Sundquist K., Hemminki K. Familial Ovarian Cancer Clusters with Other Cancers. Sci Rep. 2018;8(1):11561. doi: 10.1038/s41598-018-29888-4.</cite> [<a href="https://doi.org/10.1038/s41598-018-29888-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6070489/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30069056/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Familial%20Ovarian%20Cancer%20Clusters%20with%20Other%20Cancers&amp;author=G.%20Zheng&amp;author=H.%20Yu&amp;author=A.%20Kanerva&amp;author=A.%20Forsti&amp;author=K.%20Sundquist&amp;volume=8&amp;issue=1&amp;publication_year=2018&amp;pages=11561&amp;pmid=30069056&amp;doi=10.1038/s41598-018-29888-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib5">
<span class="label">5.</span><cite>Alsop K., Fereday S., Meldrum C., deFazio A., Emmanuel C., George J. BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J Clin Oncol. 2012;30(21):2654–2663. doi: 10.1200/JCO.2011.39.8545.</cite> [<a href="https://doi.org/10.1200/JCO.2011.39.8545" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3413277/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22711857/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=BRCA%20mutation%20frequency%20and%20patterns%20of%20treatment%20response%20in%20BRCA%20mutation-positive%20women%20with%20ovarian%20cancer:%20a%20report%20from%20the%20Australian%20Ovarian%20Cancer%20Study%20Group&amp;author=K.%20Alsop&amp;author=S.%20Fereday&amp;author=C.%20Meldrum&amp;author=A.%20deFazio&amp;author=C.%20Emmanuel&amp;volume=30&amp;issue=21&amp;publication_year=2012&amp;pages=2654-2663&amp;pmid=22711857&amp;doi=10.1200/JCO.2011.39.8545&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib6">
<span class="label">6.</span><cite>Zhang S., Royer R., Li S., McLaughlin J.R., Rosen B., Risch H.A. Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. Gynecol Oncol. 2011;121(2):353–357. doi: 10.1016/j.ygyno.2011.01.020.</cite> [<a href="https://doi.org/10.1016/j.ygyno.2011.01.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21324516/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gynecol%20Oncol&amp;title=Frequencies%20of%20BRCA1%20and%20BRCA2%20mutations%20among%201,342%20unselected%20patients%20with%20invasive%20ovarian%20cancer&amp;author=S.%20Zhang&amp;author=R.%20Royer&amp;author=S.%20Li&amp;author=J.R.%20McLaughlin&amp;author=B.%20Rosen&amp;volume=121&amp;issue=2&amp;publication_year=2011&amp;pages=353-357&amp;pmid=21324516&amp;doi=10.1016/j.ygyno.2011.01.020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib7">
<span class="label">7.</span><cite>Walsh T., Casadei S., Lee M.K., Pennil C.C., Nord A.S., Thornton A.M. Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci U S A. 2011;108(44):18032–18037. doi: 10.1073/pnas.1115052108.</cite> [<a href="https://doi.org/10.1073/pnas.1115052108" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3207658/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22006311/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&amp;title=Mutations%20in%2012%20genes%20for%20inherited%20ovarian,%20fallopian%20tube,%20and%20peritoneal%20carcinoma%20identified%20by%20massively%20parallel%20sequencing&amp;author=T.%20Walsh&amp;author=S.%20Casadei&amp;author=M.K.%20Lee&amp;author=C.C.%20Pennil&amp;author=A.S.%20Nord&amp;volume=108&amp;issue=44&amp;publication_year=2011&amp;pages=18032-18037&amp;pmid=22006311&amp;doi=10.1073/pnas.1115052108&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib8">
<span class="label">8.</span><cite>Godet I., Gilkes D.M. BRCA1 and BRCA2 mutations and treatment strategies for breast cancer. Integr Cancer Sci Ther. 2017;4(1) doi: 10.15761/ICST.1000228.</cite> [<a href="https://doi.org/10.15761/ICST.1000228" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5505673/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28706734/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Integr%20Cancer%20Sci%20Ther&amp;title=BRCA1%20and%20BRCA2%20mutations%20and%20treatment%20strategies%20for%20breast%20cancer&amp;author=I.%20Godet&amp;author=D.M.%20Gilkes&amp;volume=4&amp;issue=1&amp;publication_year=2017&amp;pmid=28706734&amp;doi=10.15761/ICST.1000228&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib9">
<span class="label">9.</span><cite>Roy R., Chun J., Powell S.N. BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer. 2011;12(1):68–78. doi: 10.1038/nrc3181.</cite> [<a href="https://doi.org/10.1038/nrc3181" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4972490/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22193408/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cancer&amp;title=BRCA1%20and%20BRCA2:%20different%20roles%20in%20a%20common%20pathway%20of%20genome%20protection&amp;author=R.%20Roy&amp;author=J.%20Chun&amp;author=S.N.%20Powell&amp;volume=12&amp;issue=1&amp;publication_year=2011&amp;pages=68-78&amp;pmid=22193408&amp;doi=10.1038/nrc3181&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib10">
<span class="label">10.</span><cite>Couch F.J., Wang X., McGuffog L., Lee A., Olswold C., Kuchenbaecker K.B. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet. 2013;9(3) doi: 10.1371/journal.pgen.1003212.</cite> [<a href="https://doi.org/10.1371/journal.pgen.1003212" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3609646/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23544013/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Genet&amp;title=Genome-wide%20association%20study%20in%20BRCA1%20mutation%20carriers%20identifies%20novel%20loci%20associated%20with%20breast%20and%20ovarian%20cancer%20risk&amp;author=F.J.%20Couch&amp;author=X.%20Wang&amp;author=L.%20McGuffog&amp;author=A.%20Lee&amp;author=C.%20Olswold&amp;volume=9&amp;issue=3&amp;publication_year=2013&amp;pmid=23544013&amp;doi=10.1371/journal.pgen.1003212&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib11">
<span class="label">11.</span><cite>Frank T.S., Deffenbaugh A.M., Reid J.E., Hulick M., Ward B.E., Lingenfelter B. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol. 2002;20(6):1480–1490. doi: 10.1200/JCO.2002.20.6.1480.</cite> [<a href="https://doi.org/10.1200/JCO.2002.20.6.1480" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11896095/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Clinical%20characteristics%20of%20individuals%20with%20germline%20mutations%20in%20BRCA1%20and%20BRCA2:%20analysis%20of%2010,000%20individuals&amp;author=T.S.%20Frank&amp;author=A.M.%20Deffenbaugh&amp;author=J.E.%20Reid&amp;author=M.%20Hulick&amp;author=B.E.%20Ward&amp;volume=20&amp;issue=6&amp;publication_year=2002&amp;pages=1480-1490&amp;pmid=11896095&amp;doi=10.1200/JCO.2002.20.6.1480&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib12">
<span class="label">12.</span><cite>Gabai-Kapara E., Lahad A., Kaufman B., Friedman E., Segev S., Renbaum P. Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2. Proc Natl Acad Sci U S A. 2014;111(39):14205–14210. doi: 10.1073/pnas.1415979111.</cite> [<a href="https://doi.org/10.1073/pnas.1415979111" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4191771/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25192939/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&amp;title=Population-based%20screening%20for%20breast%20and%20ovarian%20cancer%20risk%20due%20to%20BRCA1%20and%20BRCA2&amp;author=E.%20Gabai-Kapara&amp;author=A.%20Lahad&amp;author=B.%20Kaufman&amp;author=E.%20Friedman&amp;author=S.%20Segev&amp;volume=111&amp;issue=39&amp;publication_year=2014&amp;pages=14205-14210&amp;pmid=25192939&amp;doi=10.1073/pnas.1415979111&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib13">
<span class="label">13.</span><cite>Lee, E.Y. and W.J. Muller, Oncogenes and tumor suppressor genes<em>.</em> Cold Spring Harb Perspect Biol. 2(10): p. a003236.</cite> [<a href="https://doi.org/10.1101/cshperspect.a003236" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2944361/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20719876/" class="usa-link">PubMed</a>]</li>
<li id="bib14">
<span class="label">14.</span><cite>Paul, A. and S. Paul, The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers<em>.</em> Front Biosci (Landmark Ed). 19: p. 605-618.</cite> [<a href="https://doi.org/10.2741/4230" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4307936/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24389207/" class="usa-link">PubMed</a>]</li>
<li id="bib15">
<span class="label">15.</span><cite>Wallace A.J. New challenges for BRCA testing: a view from the diagnostic laboratory. Eur J Hum Genet. 2016;24(Suppl 1):S10–S18. doi: 10.1038/ejhg.2016.94.</cite> [<a href="https://doi.org/10.1038/ejhg.2016.94" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5141576/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27514839/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Hum%20Genet&amp;title=New%20challenges%20for%20BRCA%20testing:%20a%20view%20from%20the%20diagnostic%20laboratory&amp;author=A.J.%20Wallace&amp;volume=24&amp;issue=Suppl%201&amp;publication_year=2016&amp;pages=S10-S18&amp;pmid=27514839&amp;doi=10.1038/ejhg.2016.94&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib16">
<span class="label">16.</span><cite>Lancaster J.M., Powell C.B., Chen L.M., Richardson D.L., S.G.O.C.P. Committee  Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol. 2015;136(1):3–7. doi: 10.1016/j.ygyno.2014.09.009.</cite> [<a href="https://doi.org/10.1016/j.ygyno.2014.09.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25238946/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gynecol%20Oncol&amp;title=Society%20of%20Gynecologic%20Oncology%20statement%20on%20risk%20assessment%20for%20inherited%20gynecologic%20cancer%20predispositions&amp;author=J.M.%20Lancaster&amp;author=C.B.%20Powell&amp;author=L.M.%20Chen&amp;author=D.L.%20Richardson&amp;volume=136&amp;issue=1&amp;publication_year=2015&amp;pages=3-7&amp;pmid=25238946&amp;doi=10.1016/j.ygyno.2014.09.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib17">
<span class="label">17.</span><cite>George A. UK BRCA mutation testing in patients with ovarian cancer. Br J Cancer. 2015;113(Suppl 1):S17–S21. doi: 10.1038/bjc.2015.396.</cite> [<a href="https://doi.org/10.1038/bjc.2015.396" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4816269/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26669451/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Cancer&amp;title=UK%20BRCA%20mutation%20testing%20in%20patients%20with%20ovarian%20cancer&amp;author=A.%20George&amp;volume=113&amp;issue=Suppl%201&amp;publication_year=2015&amp;pages=S17-S21&amp;pmid=26669451&amp;doi=10.1038/bjc.2015.396&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib18">
<span class="label">18.</span><cite>Gayther S.A., Warren W., Mazoyer S., Russell P.A., Harrington P.A., Chiano M. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet. 1995;11(4):428–433. doi: 10.1038/ng1295-428.</cite> [<a href="https://doi.org/10.1038/ng1295-428" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7493024/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Genet&amp;title=Germline%20mutations%20of%20the%20BRCA1%20gene%20in%20breast%20and%20ovarian%20cancer%20families%20provide%20evidence%20for%20a%20genotype-phenotype%20correlation&amp;author=S.A.%20Gayther&amp;author=W.%20Warren&amp;author=S.%20Mazoyer&amp;author=P.A.%20Russell&amp;author=P.A.%20Harrington&amp;volume=11&amp;issue=4&amp;publication_year=1995&amp;pages=428-433&amp;pmid=7493024&amp;doi=10.1038/ng1295-428&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib19">
<span class="label">19.</span><cite>Thompson D., Easton D., Breast Cancer Linkage C. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet. 2001;68(2):410–419. doi: 10.1086/318181.</cite> [<a href="https://doi.org/10.1086/318181" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1235274/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11170890/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Hum%20Genet&amp;title=Variation%20in%20cancer%20risks,%20by%20mutation%20position,%20in%20BRCA2%20mutation%20carriers&amp;author=D.%20Thompson&amp;author=D.%20Easton&amp;author=C.%20Breast%20Cancer%20Linkage&amp;volume=68&amp;issue=2&amp;publication_year=2001&amp;pages=410-419&amp;pmid=11170890&amp;doi=10.1086/318181&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib20">
<span class="label">20.</span><cite>Gayther S.A., Mangion J., Russell P., Seal S., Barfoot R., Ponder B.A. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet. 1997;15(1):103–105. doi: 10.1038/ng0197-103.</cite> [<a href="https://doi.org/10.1038/ng0197-103" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8988179/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Genet&amp;title=Variation%20of%20risks%20of%20breast%20and%20ovarian%20cancer%20associated%20with%20different%20germline%20mutations%20of%20the%20BRCA2%20gene&amp;author=S.A.%20Gayther&amp;author=J.%20Mangion&amp;author=P.%20Russell&amp;author=S.%20Seal&amp;author=R.%20Barfoot&amp;volume=15&amp;issue=1&amp;publication_year=1997&amp;pages=103-105&amp;pmid=8988179&amp;doi=10.1038/ng0197-103&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib21">
<span class="label">21.</span><cite>Rebbeck T.R., Mitra N., Wan F., Sinilnikova O.M., Healey S., McGuffog L. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA. 2015;313(13):1347–1361. doi: 10.1001/jama.2014.5985.</cite> [<a href="https://doi.org/10.1001/jama.2014.5985" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4537700/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25849179/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Association%20of%20type%20and%20location%20of%20BRCA1%20and%20BRCA2%20mutations%20with%20risk%20of%20breast%20and%20ovarian%20cancer&amp;author=T.R.%20Rebbeck&amp;author=N.%20Mitra&amp;author=F.%20Wan&amp;author=O.M.%20Sinilnikova&amp;author=S.%20Healey&amp;volume=313&amp;issue=13&amp;publication_year=2015&amp;pages=1347-1361&amp;pmid=25849179&amp;doi=10.1001/jama.2014.5985&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib22">
<span class="label">22.</span><cite>Koczkowska M., Krawczynska N., Stukan M., Kuzniacka A., Brozek I., Sniadecki M. Spectrum and Prevalence of Pathogenic Variants in Ovarian Cancer Susceptibility Genes in a Group of 333 Patients. Cancers (Basel) 2018;10(11) doi: 10.3390/cancers10110442.</cite> [<a href="https://doi.org/10.3390/cancers10110442" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6266089/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30441849/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=Spectrum%20and%20Prevalence%20of%20Pathogenic%20Variants%20in%20Ovarian%20Cancer%20Susceptibility%20Genes%20in%20a%20Group%20of%20333%20Patients&amp;author=M.%20Koczkowska&amp;author=N.%20Krawczynska&amp;author=M.%20Stukan&amp;author=A.%20Kuzniacka&amp;author=I.%20Brozek&amp;volume=10&amp;issue=11&amp;publication_year=2018&amp;pmid=30441849&amp;doi=10.3390/cancers10110442&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib23">
<span class="label">23.</span><cite>Cotrim D.P., Ribeiro A.R.G., Paixao D., de Queiroz Soares D.C., Jbili R., Pandolfi N.C. Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil. BMC Cancer. 2019;19(1):4. doi: 10.1186/s12885-018-5235-3.</cite> [<a href="https://doi.org/10.1186/s12885-018-5235-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6319008/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30606148/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=Prevalence%20of%20BRCA1%20and%20BRCA2%20pathogenic%20and%20likely%20pathogenic%20variants%20in%20non-selected%20ovarian%20carcinoma%20patients%20in%20Brazil&amp;author=D.P.%20Cotrim&amp;author=A.R.G.%20Ribeiro&amp;author=D.%20Paixao&amp;author=D.C.%20de%20Queiroz%20Soares&amp;author=R.%20Jbili&amp;volume=19&amp;issue=1&amp;publication_year=2019&amp;pages=4&amp;pmid=30606148&amp;doi=10.1186/s12885-018-5235-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib24">
<span class="label">24.</span><cite>Teixeira N, van der Hout A, Oosterwijk JC, Vos JR, Devilee P, van Engelen K, et al. The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position? <em>Eur J Hum Genet</em><strong>26</strong>(6), 848–857.</cite> [<a href="https://doi.org/10.1038/s41431-018-0111-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5974362/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29483665/" class="usa-link">PubMed</a>]</li>
<li id="bib25">
<span class="label">25.</span><cite>Rudaitis V., Zvirblis T., Kanopiene D., Janulynaite D., Griskevicius L., Janavicius R. BRCA1/2 mutation status is an independent factor of improved survival for advanced (stage III-IV) ovarian cancer. Int J Gynecol Cancer. 2014;24(8):1395–1400. doi: 10.1097/IGC.0000000000000247.</cite> [<a href="https://doi.org/10.1097/IGC.0000000000000247" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25248112/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Gynecol%20Cancer&amp;title=BRCA1/2%20mutation%20status%20is%20an%20independent%20factor%20of%20improved%20survival%20for%20advanced%20(stage%20III-IV)%20ovarian%20cancer&amp;author=V.%20Rudaitis&amp;author=T.%20Zvirblis&amp;author=D.%20Kanopiene&amp;author=D.%20Janulynaite&amp;author=L.%20Griskevicius&amp;volume=24&amp;issue=8&amp;publication_year=2014&amp;pages=1395-1400&amp;pmid=25248112&amp;doi=10.1097/IGC.0000000000000247&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib26">
<span class="label">26.</span><cite>Vencken P.M., Kriege M., Hoogwerf D., Beugelink S., van der Burg M.E., Hooning M.J. Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients. Ann Oncol. 2011;22(6):1346–1352. doi: 10.1093/annonc/mdq628.</cite> [<a href="https://doi.org/10.1093/annonc/mdq628" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21228333/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Oncol&amp;title=Chemosensitivity%20and%20outcome%20of%20BRCA1-%20and%20BRCA2-associated%20ovarian%20cancer%20patients%20after%20first-line%20chemotherapy%20compared%20with%20sporadic%20ovarian%20cancer%20patients&amp;author=P.M.%20Vencken&amp;author=M.%20Kriege&amp;author=D.%20Hoogwerf&amp;author=S.%20Beugelink&amp;author=M.E.%20van%20der%20Burg&amp;volume=22&amp;issue=6&amp;publication_year=2011&amp;pages=1346-1352&amp;pmid=21228333&amp;doi=10.1093/annonc/mdq628&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib27">
<span class="label">27.</span><cite>Gallagher D.J., Konner J.A., Bell-McGuinn K.M., Bhatia J., Sabbatini P., Aghajanian C.A. Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity. Ann Oncol. 2011;22(5):1127–1132. doi: 10.1093/annonc/mdq577.</cite> [<a href="https://doi.org/10.1093/annonc/mdq577" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6267858/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21084428/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Oncol&amp;title=Survival%20in%20epithelial%20ovarian%20cancer:%20a%20multivariate%20analysis%20incorporating%20BRCA%20mutation%20status%20and%20platinum%20sensitivity&amp;author=D.J.%20Gallagher&amp;author=J.A.%20Konner&amp;author=K.M.%20Bell-McGuinn&amp;author=J.%20Bhatia&amp;author=P.%20Sabbatini&amp;volume=22&amp;issue=5&amp;publication_year=2011&amp;pages=1127-1132&amp;pmid=21084428&amp;doi=10.1093/annonc/mdq577&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib28">
<span class="label">28.</span><cite>Bhattacharyya A., Ear U.S., Koller B.H., Weichselbaum R.R., Bishop D.K. The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J Biol Chem. 2000;275(31):23899–23903. doi: 10.1074/jbc.C000276200.</cite> [<a href="https://doi.org/10.1074/jbc.C000276200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10843985/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Biol%20Chem&amp;title=The%20breast%20cancer%20susceptibility%20gene%20BRCA1%20is%20required%20for%20subnuclear%20assembly%20of%20Rad51%20and%20survival%20following%20treatment%20with%20the%20DNA%20cross-linking%20agent%20cisplatin&amp;author=A.%20Bhattacharyya&amp;author=U.S.%20Ear&amp;author=B.H.%20Koller&amp;author=R.R.%20Weichselbaum&amp;author=D.K.%20Bishop&amp;volume=275&amp;issue=31&amp;publication_year=2000&amp;pages=23899-23903&amp;pmid=10843985&amp;doi=10.1074/jbc.C000276200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib29">
<span class="label">29.</span><cite>Foulkes W.D. BRCA1 and BRCA2: chemosensitivity, treatment outcomes and prognosis. Fam Cancer. 2006;5(2):135–142. doi: 10.1007/s10689-005-2832-5.</cite> [<a href="https://doi.org/10.1007/s10689-005-2832-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16736282/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Fam%20Cancer&amp;title=BRCA1%20and%20BRCA2:%20chemosensitivity,%20treatment%20outcomes%20and%20prognosis&amp;author=W.D.%20Foulkes&amp;volume=5&amp;issue=2&amp;publication_year=2006&amp;pages=135-142&amp;pmid=16736282&amp;doi=10.1007/s10689-005-2832-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib30">
<span class="label">30.</span><cite>Venkitaraman A.R. Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment. Annu Rev Pathol. 2009;4:461–487. doi: 10.1146/annurev.pathol.3.121806.151422.</cite> [<a href="https://doi.org/10.1146/annurev.pathol.3.121806.151422" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18954285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annu%20Rev%20Pathol&amp;title=Linking%20the%20cellular%20functions%20of%20BRCA%20genes%20to%20cancer%20pathogenesis%20and%20treatment&amp;author=A.R.%20Venkitaraman&amp;volume=4&amp;publication_year=2009&amp;pages=461-487&amp;pmid=18954285&amp;doi=10.1146/annurev.pathol.3.121806.151422&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib31">
<span class="label">31.</span><cite>Kotsopoulos J., Rosen B., Fan I., Moody J., McLaughlin J.R., Risch H. Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation status. Gynecol Oncol. 2016;140(1):42–47. doi: 10.1016/j.ygyno.2015.11.009.</cite> [<a href="https://doi.org/10.1016/j.ygyno.2015.11.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26556769/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gynecol%20Oncol&amp;title=Ten-year%20survival%20after%20epithelial%20ovarian%20cancer%20is%20not%20associated%20with%20BRCA%20mutation%20status&amp;author=J.%20Kotsopoulos&amp;author=B.%20Rosen&amp;author=I.%20Fan&amp;author=J.%20Moody&amp;author=J.R.%20McLaughlin&amp;volume=140&amp;issue=1&amp;publication_year=2016&amp;pages=42-47&amp;pmid=26556769&amp;doi=10.1016/j.ygyno.2015.11.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib32">
<span class="label">32.</span><cite>Artioli G., Borgato L., Cappetta A., Wabersich J., Mocellin S., Dalla Palma M. Overall survival in BRCA-associated ovarian cancer: case-control study of an Italian series. Eur J Gynaecol Oncol. 2010;31(6):658–661.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/21319511/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Gynaecol%20Oncol&amp;title=Overall%20survival%20in%20BRCA-associated%20ovarian%20cancer:%20case-control%20study%20of%20an%20Italian%20series&amp;author=G.%20Artioli&amp;author=L.%20Borgato&amp;author=A.%20Cappetta&amp;author=J.%20Wabersich&amp;author=S.%20Mocellin&amp;volume=31&amp;issue=6&amp;publication_year=2010&amp;pages=658-661&amp;pmid=21319511&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib33">
<span class="label">33.</span><cite>Liu J., Cristea M.C., Frankel P., Neuhausen S.L., Steele L., Engelstaedter V. Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survival. Cancer Genet. 2012;205(1-2):34–41. doi: 10.1016/j.cancergen.2012.01.008.</cite> [<a href="https://doi.org/10.1016/j.cancergen.2012.01.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3337330/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22429596/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Genet&amp;title=Clinical%20characteristics%20and%20outcomes%20of%20BRCA-associated%20ovarian%20cancer:%20genotype%20and%20survival&amp;author=J.%20Liu&amp;author=M.C.%20Cristea&amp;author=P.%20Frankel&amp;author=S.L.%20Neuhausen&amp;author=L.%20Steele&amp;volume=205&amp;issue=1-2&amp;publication_year=2012&amp;pages=34-41&amp;pmid=22429596&amp;doi=10.1016/j.cancergen.2012.01.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib34">
<span class="label">34.</span><cite>Weitzel J.N., Lagos V.I., Herzog J.S., Judkins T., Hendrickson B., Ho J.S. Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev. 2007;16(8):1615–1620. doi: 10.1158/1055-9965.EPI-07-0198.</cite> [<a href="https://doi.org/10.1158/1055-9965.EPI-07-0198" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17646271/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Epidemiol%20Biomarkers%20Prev&amp;title=Evidence%20for%20common%20ancestral%20origin%20of%20a%20recurring%20BRCA1%20genomic%20rearrangement%20identified%20in%20high-risk%20Hispanic%20families&amp;author=J.N.%20Weitzel&amp;author=V.I.%20Lagos&amp;author=J.S.%20Herzog&amp;author=T.%20Judkins&amp;author=B.%20Hendrickson&amp;volume=16&amp;issue=8&amp;publication_year=2007&amp;pages=1615-1620&amp;pmid=17646271&amp;doi=10.1158/1055-9965.EPI-07-0198&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><span>Multimedia component 1</span></div>
<div class="media p" title="Multimedia component 1"><div class="caption">
<a href="/articles/instance/6931216/bin/mmc1.xml" data-ga-action="click_feat_suppl" class="usa-link">mmc1.xml</a><sup> (255B, xml) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p"><span>Multimedia component 2</span></div>
<div class="media p" title="Multimedia component 2"><div class="caption">
<a href="/articles/instance/6931216/bin/mmc2.docx" data-ga-action="click_feat_suppl" class="usa-link">mmc2.docx</a><sup> (34.9KB, docx) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Translational Oncology are provided here courtesy of <strong>Neoplasia Press</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1016/j.tranon.2019.11.003"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/main.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (967.7 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/6931216/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/6931216/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC6931216%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC6931216/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC6931216/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC6931216/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/31869745/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC6931216/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/31869745/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC6931216/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/6931216/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="A996BVFZ2wYNkWhVebzi52KtrmpyEDAocjzjnN8xjes7v2MWuaXSCaD9yeOLHo5T">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
